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This baseline study evaluated prevalence and antibiotic resistance of food-borne bacteria 
as conventional poultry facilities transition to organic practices. Poultry litter, feed, soil, 
water samples and poultry questionnaire responses were collected from 10 conventional 
and 10 organic-transitioning poultry houses from March to June 2008. Enterococcus pp. 
(n=260) and Salmonella spp. (n=100) isolates were identified to species level and 
antimicrobial susceptibility testing was performed using the Sensititre® system. 
Statistical analyses were performed using STATA 10.  Prevalence of Enterococcus pp. 
on organic-transitioning and conventional poultry farms was 100%; and prevalence of 
Salmonella spp. was 100% and 40%, respectively. Enterococcus isolates from 
conventional poultry houses displayed significantly higher percentages of resistance for 9 
antibiotic agents compared to organic-transitioning isolates.   Conversely, Salmonella 
  
spp. isolated from both conventional and organic-transitioning poultry houses exhibited 
similar antibiotic resistance patterns.  Baseline findings suggest importance of poultry 
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Chapter 1: Introduction 
I. OVERVIEW 
A. Antimicrobials and Antimicrobial Resistance  
Since the mid-20th century, antimicrobials have been utilized in the protection of human 
and veterinary health worldwide.  According to the Centers for Disease Control and Prevention 
(CDC), antimicrobial agents are defined as “drugs, chemicals, or othe substances that either kill 
or slow the growth of microbes” (CDC, 2008a).  The specificity of antimicrobials is 
characterized by target entities or organism (i.e. antibacterial drugs-bacteria; antiviral agents-
viruses; antifungal agents-fungi; and anti-parasitic drugs-parasites) (CDC, 2008a).  In tandem, 
the use of antimicrobials for the treatment of human and animal illnesses has revolutionized and 
eroded many advances of modern clinical and veterinary medicine.  Antimicrobials have 
significantly contributed to the prevention (Nadelman et al., 2001) and treatment of infectious 
diseases in humans, as well as myriad animal species.  However, the excess or overuse of 
antibiotics can generate genomic selective pressures to enable microbes to adapt and acquire 
resistance (Witte, 2000). 
  Antibiotic resistance is an evolutionary artifact of microbes adapting to environmental 
changes associated with both natural and anthropogenic stressors (Banquero, Negri, Morosini, & 
Blazquez, 1998).  The use of antimicrobials selects for resistance genes in both pathogenic and  
non-pathogenic bacteria (Aarestrup, 1999).   Due to the rapid reproduction rates of bacteria, 
resistance can emerge in occurrence with antimicrobial agents.  Re istance genes can surface in 
the bacterial gene pool.  Consequently, the elevated exposure to antimicrob als, especially at 
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chronic low levels, amplifies the pool of resistant bacteria; and increases potential risk of clinical 
infection exhibiting antimicrobial-resistance (Levy, 1998; van  den  Bogaard & Stobberingh, 
1999).     
 Nodes of antibiotic resistance can emerge in a variety of settings, ncluding hospitals 
(McGowan Jr., 1983), long-term facility (Strausbaugh, Crossley, Nurse, & Thrupp, 1996), 
community-acquired (S. Madhi, Peterson, A. Madhi, Khoosal, & Klugman, 2000) and within the 
environment (Kummerer, 2004).  The emergence of antibiotic resistance subsequently 
compromises the efficacy of drugs, chemicals, or other agents in disease treatment and 
prevention that could herald the onset into a “Post Antibiotic Era”, where the availability of 
effective antibiotics no longer exists.  Ultimately, increases in bacterial antibiotic resistance pose 
a considerable threat to public health, especially for vulnerable populati ns including young 
children (Shea, 2003), the elderly (Nicolle, Strausbaugh & Garibaldi, 1996), and 
immunocompromised individuals (Hitti & Wolff, 2005). 
 
B. Agricultural Systems and Antibiotic Resistance  
A major practice that leads to the development of bacterial antimicrobial resistance is the 
use and misuse of antibiotics in agriculture systems worldwide (Levy, 2004; Smith, Harris, 
Johnson, Silbergeld, & Morris,  2002).  Two diametric agricultural methods surround the issue of 
antibiotic usage in agricultural settings: 1) conventional farming methods that employ standard 
agricultural industry practices that involve the usage of pesticides, synthetic fertilizers, 
antibiotics and other agribusiness approaches; and 2) organic farming practices that involve the 
production of foodstuff grown or raised without synthetic fertilizers o  pesticides, antibiotics, 
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chemicals or hormones. With the transition from small-scale trditional farming to large-scale, 
concentrated animal feeding operations (CAFOs) that has occurred in the past century, 
agricultural practices have evolved to accommodate food consumption rates with increased 
agricultural output at the risk of introducing antibiotic-resistant pathogens into the environment 
(Silbergeld,  Graham, & Price, 2008). 
 In the U.S., annual estimates state that between 9 and 13 million kg f antibiotics are 
used for agricultural purposes (Shea, 2003).   Four key functions of antibiotics in agriculture 
involve: 1) therapeutic--treatment of sick animals; 2) metaphylaxis--short-term treatment for 
diseased animals and prevention of spread of disease; 3) prophylactic--prevention of infection or 
development of disease; and 4) growth promotion-- enhancement of weight gain and feed 
efficiency conversion—the amount of food converted to animal protein rather than manure 
(Mathew, Cissel, & Liamthong, 2007;  Pew Commission, 2008).  Upwards of 70% of antibiotics 
commercially produced in the United States are employed non-therapeutically in animal 
agriculture to promote farm animal growth (Mellon, C. Benbrook, & K. Benbrook, 2001). Many 
of the antibiotics used in food animal operations are human therapeutic eq ivalents or analogs in 
clinical medicine where some antibiotic usage is the only form of treatment.  For example, 
Synercid, a combination of quinupristin and dalfopristin, is a third- generation antibiotic of the 
streptogramin class approved by FDA for human use in the U.S. (FDA, 1999).  Synercid is the 
first antibiotic approved for the treatment of vancomycin-resistant Enterococcus faecium (VREF) 
infections in the presence of no alternative treatment in the U.S. (FDA, 1999).  In addition, 
approval  had been issued for use in the treatment of  complicated skin and skin structure 
infections (FDA, 1999).  Economic additional cost estimates to the U.S. healthcare system due to 
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antibiotic-resistant bacteria range from 4-5 billion dollars per year (H rison, 1998).   In addition, 
several studies have suggested that characteristics of agricultural environmental settings, 
including animal crowding, CAFO hygiene, temperature, ventilation control, and stress, can 
influence antibiotic resistance and pathogen risk (Gilchrist et al., 2007).   
 
C. Poultry Production and Antibiotic Resistance 
Intensive animal feeding production of poultry can potentially provide a suitable 
environment for the proliferation of antibiotic resistant bacteria (H yes et al., 2001 Hayes et  al., 
2003; Price, Lackey, Vailes, & Silbergeld, 2007).  Between 1945-1999, the poultry production 
industry experienced an 88 % increase in the production of broiler chickens in billion pounds per 
year (USDA, 2006).  An estimated 10.3 million pounds of antibiotics are used annually in U.S. 
poultry production for non-therapeutic purposes such as promoting growth and improving feed 
efficiency with a 307% per bird antimicrobial use increase since the 1980s (Mellon et al., 2001). 
A host of antibiotics are approved by the FDA for growth promotion in poultry production Table 
1.  
 Predominantly outside of the U.S., numerous studies have reported the use of antibiotics 
in poultry production as a causative agent in the establishment of antibiotic-resistance reservoirs 
within poultry flocks (Bager, Madsen, Christensen, & Aarestrup, 1997; Hayes et al., 2001 Hayes 
et al., 2004; Singer & Hofacre, 2006; Price et al., 2007).  Significant associations between the 
use of non-therapeutic antimicrobials and antibiotic resistance among pathogenic and non-
pathogenic bacteria have been documented in several studies investigating Campylobacter spp., 
Salmonella spp. and Enterococcus spp. recovered from conventional and organic farming 
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operations (Langtongkum et al., 2005; Gupta et al., 2004; Garcia-Migura, Pleydell, Barnes, 
Davies, & Liebana, 2005).   In recent work, research has exhibited a myri d  of  resistance 
patterns ranging between an elevation (Angkititrakul, Chomvarin, Chaita, Kanistanon, & 
Waethewutajarn, 2005;  Louge, Sherwood, Olah, Elijah, & Dockter, 2003), a reduction (Cui, Ge, 
Zheng, & Meng, 2005; Price, Johnson, Vailes, & Silbergerd, 2005), and no effect (Joseph, in 
press) in percent of antibiotic-resistant bacteria within organic and conventional farming 
operations, comparatively.  
With the meteoric rise of the organic market (i.e. organic meat is the fastest growing 
sector of the organic market share (Dimitri & Greene, 2002)), new iterest is arising with regard 
to conventional farms transitioning to organic practices to capitalize commercially from the 
organic niche (Olberholtzer, Dimitri, & Greene, 2006).  However, as the e transitions to organic 
practices occur on poultry farms, there is a paucity of knowledge concerning on-farm temporal 
changes associated with antibiotic resistance and food borne bacteria.  Limited knowledge also 
exists in elucidating the role of environmental factors on long-term antibiotic-resistant patterns 
and  prevalence of food-borne bacteria on poultry farms.   No previous or comparable studies 
have been fully assessed in the United States.  Thus, the primary objective of this study was to 
conduct a prospective, longitudinal, on-farm investigation in the United Sates to evaluate 
temporal changes in antibiotic resistance and loads of Salmonella spp. and Enterococcus spp. in 
association with the implementation of organic poultry production practices, and to further 





D. Research Rationale 
In the present study, we built upon the work of previous cross-sectional studies to 
examine the  prevalence of pathogenic/non-pathogenic bacteria and the pat erns of antibiotic- 
resistant bacteria on conventional poultry farms and farms transitioning to organic practices.  We 
also sought to evaluate the influence of environmental factors on pathogen prevalence and 
antibiotic resistance.  We hypothesized that gradual changes in microbial loads and phenotypic 
antibiotic resistance of Salmonella spp. and Enterococcus spp. would occur on organic-
transitioning poultry farms over time.  In addition, we hypothesized that associations would exist 
between environmental covariates and on-farm prevalence  and phenotypic resistance in food-
borne bacteria in poultry production environments.  The specific aims of the study include the 
following: 
1. To characterize prevalence and antibiotic resistance of  Salmonella spp. and 
Enterococcus spp. recovered from the same poultry farms over time as the farms 
convert from conventional to organic practices and discontinue the use of antibiotics  
 
2. To quantify temporal changes in on-farm antibiotic resistance and carriage of 
antibiotic resistance genes in Salmonella spp. and Enterococcus spp. during 
conversion process 
 
3. To evaluate associations over time between on-farm levels and genotypic antibiotic 





The work completed for this master’s thesis serves as the baseline data for the long-term 
prospective, on-farm study of microbial pathogen load and antimicrobial susceptibility patterns 
of commensal (Enterococcus spp.) and pathogenic (Salmonella spp.)  microorganisms associated 
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with the transitioning of large-scale conventional poultry farms to organic agricultural poultry 











  Chapter 2 








Chapter 2: Background 
I. ENTEROCOCCUS 
A. Historical Perspective 
 The genus of Enterococcus was first documented in 1899 by Thiercelin (Thiercelin, 
1899) as entérocoque – a reference to its intestinal source and appearance as pairs or short chains 
in human feces. Later described in clinical cases of endocarditis (MacCallum & Hastings, 1899) 
and via environmental isolation from sewage (Kühn et al., 2000), Enterococcus was broadly 
described as “streptococcus of fecal origin”.  Subsequent organisms of the streptococcal genus 
were identified based on fermentation activity: Streptococcus faecalis (Andrews & Horder, 
1906); Streptococcus faecium (Orla-Jensen,1919); and Streptococcus durans (Sherman, 1937).  
In 1937, a streptococci taxonomical system was developed to represent the following categories: 
pyogenic, lactic, viridians, and enterococcus.   The “enterococcus” group corresponded with 
streptococci that grew 1) at temperatures ranging from 10°C to 45°C, 2) at an adjusted pH of 9.6 
and 3) at 6.5% NaCl. These organisms also could survive temperatures upwards of 60°C for 30 
min and had the ability to split esculin (Sherman, 1937).  Within the Ent rococcus group, 
members correlated with the Lancefield serological scheme that reacted with group D antisera 
were commonly referenced as Group D Streptococcus (Murray, 1990). 
 Moreover, lesser known species of the Enterococcus group have been isolated from 
human, animal, plant and food origins.   Motile enterococci have been acknowledged since the 
early 1930’s (Motarjemi & Adams, 2006).   A Gouda cheese-derived enterococcus was 
described as “malodoratus” due to its pungent smell in 1955 and later termed S. faecalis var. 
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malodroatus (Murray, 1990).   Another notable addition, pigmented enterococci, were id ntified 
in the 1950s and a designation of S. faecium var. casselifavus (for yellow color) was later 
suggested in 1968 (Murray, 1990).  Nowlan and Deibel identified Streptococcus avium from 
poultry in 1967 (Murray, 1990).  Two watershed events ushered a taxonomical challenge for 
Enterococcus.   In 1970, Kalina recommended a separate genus for the enterococcal streptococci 
and the reassignment of S. faecalis, S. faecium, and subspecies of Enterococcus based on cellular 
arrangement and phenotypic associations; however, the proposal was largely disregarded and the 
classification as Group D Streptococcus persisted until 1984.  Withthe advent of DNA 
hybridization and phylogenetic analysis, a separate genus classifi ation of Enterococcus was 
warranted (Schleifer & Kilpper-Balz.1984) due to significant genetic distances of S. faecalis and 
S. faecium to other streptococci.  To date, the current genus classification of E terococcus is 
valid and generally accepted within the microbiological community.   
 
B. Genus Description 
 Members of the genus Enterococcus include gram positive, facultatively anaerobic cocci 
that are ovoid in form and can occur in singlet, pairs or short chains (Facklam, 2002).  
Enterococcus spp. are homofermentative lactic acid bacteria that lack cytochrome enzymes 
(Murray, 1990).   In biochemical screens,  Enterococcus spp.  normally exhibit catalase-negative 
properties; yet some strains produce pseudocatalase and can appear to b  weakly catalase-
positive (Murray, 1990).   The characteristic attributes of Enterococcus spp. include growth at 1) 
temperatures ranging from 10°C to 45°C, 2) an adjusted pH of 9.6 and 3) 6.5% NaCl, and 
survival in temperatures upwards of 60°C for 30 min (Murray, 2008).  Enterococcus also has the 
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ability to hydrolyze esculin in the presence of 40% bile salts (Sherman, 1937).   In addition, 
serological determinations involve reaction with group D antisera and limited reaction with 
group Q antisera (Murray, 1990).   Hydrolysis of pyrrolidonlyl-β-naphthylamide (PYR) is 
proficient in most representative species of enterococci.  Only two species, Enterococcus. 
casseliflavus and  Enterococcus gallinarium, demonstrate motility capabilities (Facklam, 2002).  
Enterococcus spp. can express alpha, gamma, or beta hemolysis on blood agar (Levinson, 2006). 
Since the transfer of S .faecalis and S. faecium from the genus Streptococcus to create the genus 
Enterococcus, the present number of total enterococci species is 26 based on chemotaxonomic 
and phylogenetic analysis (Schleifer, 1984). 
 
C. Ecological Habitat and Distribution 
 Enterococci reside in the microbial environment of the intestines ad v rious species can 
be isolated from nearly all mammals, in particular humans (Murray, 1990; Facklam, 2002).   To 
a lesser degree, enterococci exist in non-mammal reservoirs such as reptiles, birds, fish, insects 
and even plant communities (Aaerstrup, 1999).   As a result, Enterococcus pp. are ubiquitous in 
the natural environment and can be recovered from various environmental medi : soil (Mundt, 
1961), air (Chapin, Rule, Gibson, Buckley, & Schwab, 2005), water (Rice, Messer, Johnson, & 
Reasoner, 1995), and food (Giraffa, 2002).   Remarkably robust and resilient, Enterococcus spp. 
can tolerate a wide array of environmental conditions such as high temperatures and high pHs 
that would normally inhibit or kill most microorganisms (Hardie, 1986).  In humans, enterococci 
comprise only 1% of the enteric microflora, but are characterized by an unexpected spectrum of 
species diversity (Tannock & Cook, 2002).   Species composition and dominance vary within the 
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intestines and across geographical landscapes (Blanch et al., 2003).  In some parts of the world, 
E. faecalis exerts antibiotic resistance prominence.   For example, Manson, Keis, Smith, & Cook 
(2003) attributed the presence of a clonal lineage of VanA-type E. faecalis which dominates in 
vancomycin-resistant Enterococcus (VRE) isolated from poultry and  humans in New Zealand.  
The specific ecological and/or microbiological mechanisms promoting such selection of 
intestinal colonization are largely unknown (Murray, 1990).   
 
D. Epidemiology and Pathogenicity 
 Enterococci are commensal bacteria with notable recognition as pportunistic pathogens 
of increasing public health importance (Huycke, Sahm, & Gilmore, 1998).   Regarded as a 
minimal-grade pathogen, Enterococcus spp. were historically considered of nominal clinical 
impact, primarily affecting immunocompromised and sensitive individuals (Murray, 1990).   
Since the late 1990’s, Enterococcus spp., however, have emerged in clinical significance as a 
leading cause of nosocomial or hospital-acquired secondary infections (Weinstein, 1998).  E. 
faecalis and E. faecium are the most prevalent enterococci isolated from clinical human 
Enterococcus infections, accounting for 80-90% and 15-20% of infections, respectively. 
Enterococci-mediated nosocomial infections is the third most common cause of nosocomial  
infections in the United States (Schaberg, Culver, & Gaynes, 1991) resulting in approximately 1 
out of every 8 hospital-acquired infections each year (CDC, 2008b).   In addition, enterococci are 
the leading cause of surgical-site infections and the third leading cause of bloodstream  sepsis 
infections (Richards, Edwards, Culver, & Gaynes, 2000) and are implicated in bacterial 
endocarditis, intraabdominal infections, bacteremia, and meningitis (Huycke et al., 1998).  
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Specifically, Enterococcus is also directly associated with approximately 110,000 urinary trct
infections, 25,000 bacteremias, 40,000 wound infections, and 1,100 cases of endocarditis yearly 
in the United States (Huckye, 1998).  Select risk factors associated with the acquisition of 
nosocomial enteroccocal infections include: gastrointestinal colonization, prior underlying 
conditions, prolonged hospital stays, transplantation, and prior antibiotic treatment (ODH-IDCM, 
2007). 
 The pathogenicity of Enterococcus spp. entails the general colonization of mucosal 
surfaces with these organisms (Johnson, 1994). Presently, E erococcus employs a variety of the 
microbial mechanisms for the colonization and factors that influence colonization of one species 
over another in the intestinal tract are also not well understood (Jett, Huycke, & Gilmore, 1994). 
However, it is known that pathogenicity of the bacterium involves a number of steps: a. secretion 
of cytolysins and other toxins that breach cellular membranes, b. evasion of host immune system 
defenses, and c. adherence factors (Murray, 1990).   
 
E. Antibiotic Resistance 
 Virulence of Enterococcus is heavily coupled with their inherent or acquired resistance to 
antibiotics (Mundy, Sahm, & Gilmore, 2001).  As defined by the World Health Organization 
(WHO), antibiotic resistance is “a natural biological phenomenon which can be amplified or 
accelerated by a variety of factors; where microbes over time acquire the ability to adapt to 
concentrations of antimicrobial agents” (WHO, 2002).  Inherent resistance is a genetically 
mediated resistance to antibiotics which is non-transferable (Murray, 1998).  Most Enterococcus 
spp. are innately resistant to cephalosporins and the semi-synthetic peni illinase-resistant 
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penicillins (e.g., oxacillin), many Beta-lactomases and low levels of aminoglycosides (Murray, 
1998).  Acquired resistance in Enterococcus is a result of the mutation of existing DNA (i.e. 
mutations) or the conference of resistance via genetic elements such as transposons and or 
plasmids.  Enterococcus spp. are genetically “promiscuous” and easily exchange resistance-
encoding genes to other Enterococcus or potentially more virulent non-Enterococcus species, i.e. 
Staphylococcus aureus (Noble, Virani, & Cree, 1992).  Studies have documented the transfer of 
antibiotic resistance genes across species’ ranges (Kuhn et al., 2000).  As a result, multi-drug 
resistant (MDR) Enterococcus has steadily increased in the last two decades (Huycke et al., 
1998).  Enterococci acquired gentamicin resistance in 1979 (Eliopoulos, 1988) followed, in 
tandem, by penicillin resistance (Murray, 1990) and β lactamase resistance (Murray, 1990) 
during the early 1980’s. Vancomycin represents one of the last antimicrobial strongholds against 
enteroccocal infections (Morris et al., 1995).   However, vancomycin resistant Enterococcus or 
VRE has become a significant public health concern (CDC, 2008b).  Increased incidence of VRE 
infections have ballooned twenty-fold from 1989-1993 in the US (MMWR, 1993).  The 
incidence of hospitalizations with vancomycin-resistant E erococcus increased from 4.60 to 
9.48 hospitalizations per 100,000 people during 2003–2006 (Ramsey, 2009).  The relative risk of 
death associated with antibiotic-resistant enterococci is several folds higher than that of 
susceptible enterococci (Edmund, Ober, Weinbaum, & Wenzel, 1996).   Thus, the issue of 
antibiotic-resistant enterococci, specifically, VRE, has surfaced as an escalating public health 






A. Historical Perspective 
 The discovery of Salmonella is well documented in recorded history. As early as the mid-
1800s, scientific interest in Salmonella was initiated by the organism’s potential etiological 
associations with typhoid fever (Cunha, 2004).   Salmonella was first alluded to as a source of 
infection in typhoid fever patients following the confirmation of typhoid transmission via the 
fecal-oral route by William Budd in 1873 (Ellermeier & Slauch, 2006).   Karl Eberth (1835-
1926) noted rod-shaped organisms in the lymph nodes and spleens of typhoid patients in 1880 
(Ellermeier & Slauch, 2006).  The first successful cultivation of Salmonella serovar Typhi was 
performed by George Gaffky (1850-1918) from German patients in 1884 (Ellermeier & Slauch, 
2006).  Concurrently, a non-human Salmonella spp., Salmonella  choleraesius, was isolated from 
a swine’s intestine by Theobald Smith (1859-1934) under the direction of Daniel E. Salmon 
(1850-1914) in 1885 (Ellermeier & Slauch, 2006).   In 1890, the term “Salmonella” became the 
established moniker for subsequent representative bacteria of the genera in tribute to the 
scientific contribution of Salmon (Ellermeier & Slauch, 2006). 
 
  B. Genus Description 
 Members of the genus Salmonella are Gram-negative, motile, facultatively anaerobic,  
bacilli belonging to the family Enterobacteracae (Ellermeier & Slauch, 2006).   Salmonella are 
comprised of two central species, Salmonella enterica and Salmonella bongori.  The 
nomenclature of Salmonella species has  been marred by the traditional method of recognizing 
different serovars of Salmonella as distinct species (Brenner et al., 2000).   Presently, six 
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subdivisions of Salmonella enterica subspecies I-VI exist with over 2500 serovars currently 
identified and several common serovars to human clinical infections (Table 2).   Serovars are 
distinguished by their flagellar protein (H), lipopolysaccharide (O), carbohydrate composition 
and at times capsular (Vi) antigen (Coburn, 2007).  Strains associated with subspecies I indicate 
sources of human and warm-blooded origin.  Whereas, the remaining subdivisions, as well as S. 
bongori, usually originate from the environment and ectoderms.  Typical cell morphology is rod 
shaped bacteria with cell size varying from 0.7-1.5 µm by 2-5 µm with growth conditions 
ranging from 7-48°C-- optimal growth for Salmonella spp. is at 37C (Ellermeier & Slauch, 
2006).   Salmonella spp. are neutrophiles with optimal growth at pH 6.5-7.5 (Ellermeier & 
Slauch, 2006).   In addition, a water activity (Aw) level of 0.995 is ideal for maximum 
Salmonella growth (Cox, 1999).   Prior research has determined that surface litter Aw levels 
greater than 0.90 appear to be predictive of Salmonella contamination in broiler and roaster 
houses (Carr et al., 1995).  Characteristically, Salmonella spp. exhibits hydrolysis of 4-
methylumbilliferyl caprylate (MUCAP), production of hydrogen sulfide, and the inability to 
metabolize lactose or sucrose (Ruiz, 1996).  For the remainder of this document, Salmonella 




C. Ecological  Habitat and Distribution 
 Salmonella spp. are ubiquitous in nature with a widespread geographical and 
epidemiological distribution (Porwollik, 2002).  The internal habitat of Salmonella is mainly 
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resigned to the intestinal region of animals (Ellermeier & Slauch, 2006).   Salmonella spp. can be 
isolated from nearly every environmental reservoir including soil (Ba oda, Suraj, Christensen, & 
Trajcevska, 2001), vegetation (Beuchat, 2002), water (Yu & Bruno, 1996), animal (Jones, 1976) 
and food (White et al., 2001).  The distribution of Salmonella can vary greatly depending on the 
serovar.   Generalist species such as Salmonella  ser. Enteritidis and Salmonella ser. 
Typhimurium  have established global niches (Ellermeier & Slauch, 2006).   However, many 
host-restrictive serovars are bound to specific geographical regions (Uzzau et al, 2000).  
Salmonella is found routinely where intensive agriculture practices are prevalent.   From an 
agricultural perspective, Salmonella spp. are regularly isolated from infected food-producing 
animals, animal feeds, animal foodstuffs, especially of milk-, meat- or egg origin, and even 
within the farm environment as a reservoir.   With optimal growth at 37°C, Salmonella, 
specifically, S. enterica is well suited for growth in warm-blooded animals.   In contrast, all other 
S. enterica subspecies and S. bongori exhibit a commensal relationship with poikilotherms or 
cold-blood animals, i.e. reptiles, amphibians or fish (Ellermeier & Slauch, 2006).   The serovar 
group S. enterica  is further categorized by host range (Ellermeier & Slauch, 2006).  The three 
main host range classifications include: a. host adapted: infection of one host but with the 
capacity to cause disease in others; b. host-restricted: infection of only a single host; and c. 
generalist: infection of a plethora of animals but disease manifestation varies in different hosts 
(Uzzau et al. 2000; Edwards, Olsen, & Maloy, 2002).  For example, S. typhi is a host-restricted 
human pathogen (Ellermeier & Slauch, 2006).  In many reptile and avian species, Salmonella 
infection is endemic but usually asymptomatic (Seepersadsingh & Adeisyun, 2003).  Vehicles 
for continued persistence in the environment include a. fecal shedding of symptomatic and 
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symptomatic animals; b. contact with Salmonella-infected individuals, c. ingestion of 
contaminated food products (Winfield & Groisman, 2003).   Studies have isolated the presence 
of Salmonella typhimurium and Salmonella dublin in the environment in excess of a year 
(Humphrey, 2001).  The ecological resilience of Salmonella can be credited to their pathogenic 
diversity which promotes its evolution with their hosts and in the enviro ment (Bäulmer, Tsolis, 
Ficht, & Adams, 1998). 
 
D. Epidemiology and Pathogenicity 
 Salmonella is a leading cause of food-borne mortality and morbidity in the United States 
(MMWR, 2008).   The clinical manifestation of Salmonella infection presents as Salmonellosis, 
an enteric condition which ranges in severity from self-limiting gastroenteritis to septicemia 
(Shere et al., 1998).  The severity of disease depends heavily on host susceptibility and the 
virulence of the serovar.   All serovars can produce all forms of salmonellosis; however, a given 
serovar is usually syndrome-specific (Ellermeier & Slauch, 2006).   For example, Salmonella 
choleraesuis is normally associated with septicemia (Uzzau et al., 2001).   Salmonella 
asymptomatic carriage is experienced in five percent of the human population (Perreten et al., 
2005).   With correspondence to disease outcome, strains of Salmonella are grouped as typhoidal 
and non-typhoidal organisms (Ellermeier &  Slauch, 2006).   An estimated 1.4 million cases per 
year of gastroenteritis and enteric fever in the United States can be attributed to non-typhi 
Salmonella (Mead et al., 1999).   Accounting for 10% of food-borne illness in the U.S., the 
incidence of Salmonellosis occurs at a rate of 16.20 cases per 100,000 a year (MMWR, 2008). 
With respect to food-borne illnesses, Salmonellosis, contributes to 26% of the hospitalizations ( 
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~15,000 /year) and 31 % of deaths (400-600 deaths/year) (Voetsche et al. 2004).  Transmission 
of Salmonella spp. occurs via the fecal-oral route with fomites and insect vectors, i.e. flies, also 
playing major roles in the spread of Salmonella (Mian, 2002).  Vertical transmission of 
Salmonella spp. has been documented in avian species via the infection of the vitelline 
membrane, albumen and potentially egg yolk (Berchieri Jr., 2001).  In mammalian species, in 
utero transmission of Salmonella has been confirmed (Ault, Kennedy, Seoud, & Reiss,1993).   
Salmonella exhibits a seasonal pattern with the highest incidence of attributable food-borne 
illness occurring during the summer (D’Souza et al., 2004).   
 The majority of isolates that cause disease in humans and animals are classified under the 
S. enterica category (Brenner et. al., 2000).   In 2007, the most common human-derived serovars 
were S. enteritidis and S. typhimurium, making up, in total,  36% of confirmed cases in the 
United States (MMWR, 2008).  Other important serovars associated wi h human infections 
include S. typhi, S. paratyphi and S. hirshfeldii  . Infections from specific human pathogens, 
serovars Typhi and Paratyphi, result from the ingestion of fecal-contaminated consumables, e.g. 
food or water and contact with current or chronic carriers of typhoid fever (Miller & Pegues, 
2000).   Due to elevated standards of water and waste sanitation, typhoid fever is relatively 
uncommon in the United States, approximately 400 cases per year (CDC, 2005).  Over two-
thirds of recognized cases in the United States result from international travel to endemic 
countries such as India or South Africa with incidence rates of 980 and 850 cases /100,000 per 
year, respectively (Bhan, Bahl, & Bhatnagar, 2005).  Typhoid fever is a global health issue of 
eminent public health concern.   Worldwide, typhoid affects over 21.6 million cases with a case-
fatality rate ranging from 10-35% (Maskalyk, 2003; Crum, 2003).  
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The pathogenicity of Salmonella is a complex cascade of microbial and metabolic events.  
All salmonellae express virulence regardless of source and host status, e.g. carrier state (Ohl & 
Miller, 2001).  Pathogenicity is mediated by certain factors such as strain virulence, infectious 
dose, route of infection, and host susceptibility (Groisman, Fields, & Heffron, 1990).   M cells 
are the target cells of Salmonella pathogenicity (Ohl &  Miller, 2001).   If the proportion of 
vacant M cells to Salmonella spp. is high, manifestation of disease will occur.  The status of the 
normal intestinal flora dictates target cell vacancy.  Aberrations in the intestinal micro-
environment, e.g. antimicrobial therapy, create suitable conditions for Salmonella to gain access 
to M cells (Ohl & Miller, 2001).  Adhesion and assimilation into the M cell target ar  initial steps 
of Salmonella pathogenesis.  After which, Salmonella are located in the submucsoal tissue and 
the lymph nodule.  Salmonella excrete enterotoxins that create a toxin-induced response in the
form of diarrhea and abdominal pain.  Dissemination and reproduction of Salmonella spp. take 
place within phagocytic cells (Slauch et al., 1997); resulting in most gastroenteritis symptoms of 
Salmonella infection.   
 
 
E. Antibiotic Resistance 
 Amongst Salmonella spp., antibiotic resistance is a well confirmed phenomenon.  
Animals are the primary source of zoonotic  salmonella.   Combined with intensive animal 
agricultural practices, including the therapeutic, prophylactic and non-therapeutic use of 
antibiotics, selection for antibiotic-resistant strains of Salmonella became inevitable.  As early as 
the mid-1960s, outbreaks of resistant Salmonella spp. have been observed within animal 
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populations (Threlfall, 2002).  S Typhimurium isolated from cattle has demonstrated resistance to 
ampicillin, chloramphenicol, kanamycin, neomycin, streptomycin, sulfonamides, tetracycline, 
and furazolidone (Threlfall, Ward, Frost, & Willshaw,2000). Multi-drug resistant S. 
Typhimurium DT104 consistently display antibiotic resistance patterns to five different 
antibiotics (Threlfall, 2000).  Epidemic strains have exhibited resistance to approximately nine 
antibiotics (Baggesen, 2000).  As reported by NARMS, 14.8% of non-Typhi Salmonella isolates 
were resistant to 2 or more Clinical and Laboratory Standards Institute (CLSI) subclasses of 
antibiotics and 7.6 % were resistant to 5 or more CLSI subclasses in 2005 (NARMS, 2005).  
With respect to S. typhimurium, 33.2% of isolates were resistant to 2 or more CLSI subclasses 
with 23% being resistant to 5 or more CLSI subclasses (NARMS, 2005).   Recently, a multi-drug 
resistant strain of Salmonella enterica serovar Newport has become established in the U.S. and 
caused several outbreaks associated with retail meat and milk (Gupta et al., 2003).  Genetic-
relatedness of the S. newport U.S. strains has been detected in Japan giving credence to the 
global spread of multi-antibiotic resistance (Ishiguro, 2004).  
 
 
III. POULTRY PRODUCTION IN THE UNITED STATES 
 The United States ranks as the world’s leader in poultry producti n and second in egg 
production (USDA-ERS, 2009).  The designation of “poultry” encompasses all domesticated 
fowl raised for the production of meat and eggs (USDA-ERS, 1999).  The production of poultry 
includes the rearing of chickens, turkeys, ducks, geese; as well as more exotic species such as 
emus, ostrich and a variety of game birds.  The geographic distribution of U.S. poultry 
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production is concentrated within four regions (Northeast, Appalachian, Delta, and Southeast) 
representing more than 70 percent of total U.S. poultry value (USDA-ERS, 1999).   According  
to the Economic Research Service (ERS) (under the direction of the United States Department of 
Agriculture (USDA)), the on-farm value of U.S. poultry production totaled 31.9 billion in 2007 
(USDA-ERS, 2007).  Within the U.S. poultry industry, total production (farm value in dollars) 
was comprised of: broilers- $21.5 billion (67%); eggs -$6.68 billion (21%); turkey- $3.71 billion 
(12%); and others- $50.8 million (1%) in 2007 (National Ag Statistics Service (NASS), USDA, 
2008).  In particular, U.S. production of broilers, industry name for “young chickens raised 
exclusively for meat production”, has steadily increased over the last two decades. Production of 
broilers exceeded over 8.05 billion pounds (Figure 2) in 2007, representing nearly 83% of the 
total birds produced that year.  Top broiler producing states (in thousands of birds produced) 
include Georgia (1,398,800), Alabama (1,014,900) and Mississippi (824,000) (Figure 3) (USDA-
NASS, 2006).  Commercial demand has acted as a significant economic driver of U.S. poultry 
production with modifications of U.S. meat-consumption patterns beginning in the late 1960’s 
(USDA-ERS, 1999).  The consumption of poultry averaged 86 pounds per person in 2006, triple 
the 1960 consumption levels (USDA-ERS, 2008b).  Dovetailing U.S. consumption patterns, 
demand for poultry worldwide has yielded a thriving avenue for exportatin of U.S. poultry 
products (Windhorst, 2007).   The United States dominates as the world’s lea er in exportation 
of poultry products with the European Union and the Russian Federation as major i porters of 
U.S. poultry products in 2007 (AgMRC, 2009).  
 The enterprise of poultry production has evolved since its recorded inc pt on in early 
1900’s (USDA-ERS, 1999).   Historically, poultry production was relegated to the small farms 
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and yards of rural America (USDA-ERS, 1999).   As an outgrowth of te egg industry, poultry 
production existed for the sole traditional purpose of sustenance living and the local retail 
market.   Poultry production was characteristic of small “backyrd” flocks of 10-50 chickens and 
processing of poultry products occurred either close to the source farm or to consumers (USDA-
ERS, 1999).  In the late 1940’s,  a new era of poultry production was ushered in with 
developments in technology, market demand, and policy that lowered poultry production costs to 
allow for increased profitability (Reimund et. al, 1981).  Agricultural research significantly 
spearheaded the expansion in commercial poultry production with advances in nutrition and 
disease control, introduction of new breeds, management of poultry environments and products 
(USDA-ERS, 1999).  These major contributors enabled poultry production to be a profitable, 
productive and viable business venture for the agricultural community (USDA-ERS, 1999).  The 
metamorphosis of the poultry industry led to the abandonment of small-scale poultry operations 
(flocks of less than 100) and the adoption of large-scale industrial endeavors with flocks of 
upwards of 500,000 (USDA-ERS, 1999).   
 Subsequently, rapid growth of the poultry industry and commercial demand has aided in 
the present-day “conventional” farming of poultry.  Conventional farming is defined as standard 
agricultural practices used widely throughout the U.S. industry that include the use of antibiotics, 
other antimicrobials and genetically modified organisms (GMOs) in feed.  Figure 4  illustrates 
the conventional practice of poultry production in the United States.   A distinctive feature of 
conventional poultry production in the United States is the organizational scheme.  The majority 
of the U.S. poultry industry operates under a vertically integrated production system (Figure 6) 
(NCCES, 2007).  Vertical integration is a distinct mechanism of shared obligation of production 
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and processing expenditures via contractual affiliations between farmers and poultry companies 
(USDA-ERS, 1999).  Poultry companies or “integrators” own the processing facilities, 
hatcheries, and feed mills.  Integrators establish production contracts with independent poultry 
“grow-out” farms for the raising of broilers to market weight (USDA-ERS, 1999).  Contract 
farmers are commonly responsible for providing the land, poultry house(s), and equipment 
(USDA-ERS, 1999).  As well, contractors absorb the costs of labor, utilities, insurance, taxes, 
waste disposal, and other miscellaneous farm expenses (NCCES, 2007); whereas, the integrator 
firm generally supplies the feed, bird flocks, medications and supplies.   Financial compensation 
of the contract growers is related to the grower’s performance (amount of birds produced) 
(USDA-ERS, 1999).  The arrangement is mutually beneficial: contract farmers avoid large 
capital investments in feed and birds with less market risk and integrators profit from a constant 
supply of products with less long-term investment (NCCES, 2007).   After World War II, ve tical 
integration progressively became the standard amongst poultry producers in the U.S (USDA-
ERS, 1999).   By 2003, more than 90 percent of the poultry in the United States was vertically 
integrated (AgMRC, 2009).  Top producers include (in order of production ranking): Tyson 
Foods, Inc.; Pilgrim’s Pride Corp; Gold Kist; Perdue Farms and Sanderson Farms (AgMRC, 
2009). 
 
IV. ORGANIC FARMING AND POULTRY  
 Organic farming has steadily emerged as an important division of agriculture in the 
United States (AREI, 2006).  Organic agriculture is defined as “an ecological production 
management system that promotes biodiversity, biological cycles and soil health” (NAL, 2007). 
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Since the adoption of the Organic Foods Production (OFP) Act of 1990, national organic 
standards have been created for the certification of organic farmland and livestock (NAL, 2007). 
The extent of organic farming and certified organic farmland quadrupled from 1990 to 2005, and 
in 2005, all 50 states in the U.S. had certified organic farmland (USDA-ERS, 2002.).  Organic 
acreage of farmland systems are categorized by farm productin outputs with cropland and 
rangeland representing 1.7 and 2.3 million acres, respectively (USDA-ERS, 2002).   
 Although the practice of organic agriculture is expanding and reaches over 120 countries, 
obstacles for overall adoption still exist (Morgan & Murdoch, 2000).   Certain hindrances to 
organic adoption practices involve high managerial costs, risks associted with organic 
transitioning, shortages of organic grains, lack of knowledge regarding organic farming systems, 
and lack of certified organic processing plants (USDA-ERS, 2002).  Nonetheless, the incentive 
for organic-transition remains with reference to lower input costs, conservation of nonrenewable 
resources, capitalization on growing niche markets, and ultimate incr ases in farm income 
(SARE, 2007).   
 Within the organic food market, organic meat is the fastest growing sector with growth of 
over than 67.4 percent to 114 million in 2005 (Figure 5) (NFM,  2006).  Organic meat and 
poultry are considered “gateway” organic products or first organic commodities purchased by a 
consumer which could dictate future organic purchasing of other products s h as cereal or 
snacks (Dermitt, 2004).  Other gateway products include produce, dairy, soy, and baby foods 
(Dermitt, 2004).  Consumer demand for organic meat and poultry have been driv by issues 
surrounding overuse of antibiotics and growth hormones, the inhumane treatment of livestock, 
and the natural environment (NBJ, 2004).  The organic meat market, as a whole, has been 
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influenced by the competing “natural” meat industry which is not required to meet USDA 
organic regulations (USDA-NOP, 2003).   
 Organic poultry is the largest sector of the organic meat industry (OTA, 2006).  
Representing 1 percent of the total poultry market, organic poultry production has quadrupled 
since 2003 with over 13 million of birds in 2005 (Figure 7) (OTA, 2006).   Figure 4 depicts a 
typical organic poultry production facility.  California, Pennsylvania, Nebraska and Iowa 
comprise the top four U.S. states for organic broiler production and accounted for approximately 
94 percent of total U.S. organic poultry production in 2005 (Table 3).  There is limited 
knowledge about the structure of the organic poultry industry with some companies being 
vertically integrated while other poultry companies operate via personal relationships (USDA, 
2007).  Organic poultry are reared organic from at least day two of life and are at market weight 
in 70 to 81 days (Dimitre & Greene 2006).  The demand for organic poultry has outpaced the 
supply of organic broilers (AgMRC, 2008).  Consumer interest in organic poultry has steadily 
intensified with more than 7 out of 10 individuals purchasing organic chicken (USDA, 2008).  
However, hindrances associated with adherence to the OFP Act of 1990 have considerably 
stifled the short-term industry growth (Greene, 2007).   The exceedingly high cost of feed, 
representing 70% of poultry production expenditures, is a specific obstacle to organic poultry 
market expansion (Greene, 2007).  Yet despite this and other obstacles, organic poultry 





V. ANTIBIOTIC USAGE AND ANTIBIOTIC RESISTANCE IN 
AGRICULTURE 
 
 The use of antimicrobials in agriculture is a prevalent practice in food animal production.  
According to Aaerstrup et al. (1999), over 50% of all antimicrobial usge is attributed to food 
animal production.  In the United States and  abroad, a wide array of antimicrobial agents are 
utilized in food animal production (Silbergeld et al., 2008).  Table 4 depicts the registered 
antimicrobials of clinical importance that are used in animal agriculture (FDA, 2004).  In food 
animal production, antimicrobials are administered for therapeutic means for treatment of 
infection, prophylactic purposes in advance of symptomatic and asymptomatic conditions, and 
non-therapeutic purposes for growth promotion and improved feed efficiency (Wegener, 2003).  
The use of growth promoting agents (GPAs) in feed preparations or wate supplements illustrate 
the largest segment of antibiotic use in poultry production (Mellon et al., 2001).   In compliance 
with USDA mandates, GPAs are characterized as “as antibiotics supplements added to the feed 
of food animals to enhance growth rate and production performance” (Wgener et al., 1999).   
This differs greatly from antibiotic use for therapeutic and prophylactic purposes which are 
normally dispensed under higher dosage regimes.  To date, a limited body of literature exists 
substantiating the assertion for improved effects on growth rates, feed conversion efficiencies or 
general flock quality by way of GPAs (Graham, Boland, & Silbergeld 2007). 
 An accurate total concerning the amount of antibiotics used for non-therapeutic purposes 
in animal agriculture remains elusive.  The Union of Concerned Scientist conjectures that 24.6 
million pounds of antibiotics are utilized for non-therapeutic purposes (Mellon et al., 2001).   In 
contrast, the Animal Health Institute purports that a total of 17.8 million pounds of antibiotics are 
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used in animal agriculture for the entire spectrum of purposes (AHI, 2000).  Overall, the current 
estimate of non-therapeutic usage of antibiotics in food animal producti n ranges between 3.1 
million pounds to upwards of 25 million pounds in the United States, annually (Mellon et al. , 
2001; AHI, 2000).  The historic administration of non-therapeutic antibiotics for growth 
promotion was commercially pioneered in late 1940s and universally adopted within five years 
(Jukes, 1953).   Jukes (1953) contended that the use of a chlortetracycline-ame ded meal 
produced faster growing chicks in comparison to soybean-feed counterparts.  Mechanisms of 
growth promotion efficacy are unknown (Visek, 1978).  Current dosage of GPAs is prescribed at 
concentrations below 200 grams per ton of feed for a minimum of 14 days (USDA, 2006).   
 The usage of GPAs in food animal production is a major public health threat because this 
practice can contribute to the emergence of antimicrobial resistance worldwide (Levy, 2004; 
Silbergeld et al., 2008).  A myriad of factors contribute to the ris and extent of antimicrobial 
resistance in both pathogenic and commensal bacteria. Levy et al. (1998) theorizes that the 
amount and method of antibiotic administration used in food animal production promote the 
selection of antibiotic-resistant bacteria.   Chronic, low-level doses of antibiotics, characteristic 
of GPAs administered in the animal production environment, encourage the limination of 
susceptible bacteria and yield the expansion of resistant bacteria populations (W tte, 2000).   
 Constitutive and acquired are two forms of resistance to antimicrobial agents (S. 
Normark & B. Normark, 2002).  Constitutive resistance refers to resistance associated with the 
lack of cellular mechanisms needed for antibiotic susceptibility (S. Normark & B. Normark, 
2002).  Whereas, acquired resistance denotes genetic-based resistanc  via chromosomal mutation 
or the attainment of antibiotic resistance genes via horizontal gene transfer (Prescott, 1999).  
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Certain significant mechanisms of antimicrobial resistance ivolve the following: a. enzymatic 
inactivation of antibiotics, b. failure of antibiotics to permeate through the bacterial cell wall, c. 
alteration in target receptors, and d. development of enzymes/proteins with lo  drug affinity 
(Mazel, 1999).   
 The clinical importance of bacterial antibiotic resistance is well noted among commensal 
and pathogenic bacteria in numerous peer-reviewed studies.   Barza et l. (2002) estimated that 
an attributable fraction of between 13% and 26% of drug‐resistant Salmonella infections are 
acquired through an antibiotic resistance.  Many drugs used in veterinary medicine have identical 
analogs that are used in human medicine (Khachatourians, 1998: Smith, 2005).   Animal-derived 
antibiotic-resistant bacteria can colonize the intestinal flora of humans.   Donabedian et al.  
(2003) provided molecular evidence of animal –human transfer of gentamicin resistance in 
Enterococcus isolates through food.   To address concerns associated with antimicrobial 
resistance, the National Antimicrobial Resistance Monitoring System (NARMS) was established 
in 1996 to survey antibiotic-resistant bacteria in humans, retail meats and the agricultural 
environment (NARMS, 2009).  Ultimately, extensive and improper use of antibiotic drugs in 
food animal agriculture can establish reservoirs of antibiotic-resstant bacteria, greatly impacting 










Chapter 3: Methodology 
 
 
I. STUDY SITE DESCRIPTION  
 Two types of farms were included in this study: large-scale onventional poultry farms 
that housed >15,000 broilers per house (control farms), and large-scale conv ntional poultry 
farms that were within the first year of transitioning to organic practices (intervention farms). 
Characteristic differences between the conventional and organic-trasitioning poultry farms (see 
Glossary) included size, birds/house, amount of sunlight, and antibiotic and chemical usage.  All 
farms were located in the Mid Atlantic region of the U.S.  
 
II.  SAMPLE COLLECTION 
 From March 2008- June 2008, environmental samples were collected from control 
poultry houses (n=10) and intervention poultry houses (n=10).  Three main types of samples 
were collected from each house: poultry litter, water, and feed. 
Three 500g poultry litter samples (~500g) from the top 1 to 2 cm of litter were aseptically 
collected from 3 locations defined by a 0.5-1.0 m2 area within each poultry house.  One sample 
was collected in the middle of the house away from automated feed and water lines, one sample 
was collected from beneath automated feed lines and one sample was collected from beneath 
automated water lines.   Air flow, water activity (Aw) and ambient light also were measured at 
each poultry litter sampling location.   Air flow and ambient light were measured using a light 
meter, respectively, six inches above each litter sampling location and Aw was measured using a 




 Two water samples (~600 mL) were retrieved using sterile Whirl-Pak® collection bags 
(Nasco, Fort Atkinson, WI ) from raw source water (before any possible UV or chlorination 
treatment) and finished water (water provided to broilers after any possible UV or chlorination 
treatment) from each poultry house.  One poultry feed sample (~ 300 g) was collected in a sterile 
Whirl-Pak® collection bag (Nasco, Fort Atkinson, WI ) from the feed hopper within each house. 
All poultry litter, water and feed samples were mailed overnight and processed in the laboratory 
for the cultivation and isolation of Enterococcus pp. and Salmonella spp. within 24 hours.   
 
III. POULTRY FARM QUESTIONIARRE: Environmental Indices 
To elucidate the influence of environmental factors on prevalence of susceptible and 
antibiotic-resistant bacteria at all participating farms, a study questionnaire was developed (See 
Appendix).  Data concerning ambient conditions were collected by includi g questions about the 
date, season, ambient air temperature inside and outside of poultry houses, relative humidity 
inside and outside of poultry houses and rainfall. Breeder practice data was collected by 
including questions regarding the types of breeder birds, breeder company, and antibiotic usage 
on breeder farm.  Hatchery practices variables incorporated informati n involving hatchery 
company name and antibiotic usage at hatchery.   In reference to grower farm characteristics, 
examined environmental variables included the following: grower company, number of weeks 
since transition to organic practices began, geographic locations, distance to other conventional 
or organic poultry farms, poultry house size, type of ventilation system in poultry house, air flow 
in poultry house; square footage allowance per bird, average time spent outside by flock per day, 
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amount of sunlight in poultry house, type of water in nipple feeders, type of feed, type of poultry 
litter, poultry litter management practices, poultry litter water activity.  Lastly, bird 





A. Isolation and Enumeration of Enterococcus spp. and Salmonella spp. 
from Water 
 
Isolation of  Enterococcus spp.  and Salmonella spp. from water samples was performed 
in accordance with standard membrane filtration methods: U.S. Environmental Protection 
Agency (EPA) Method 1106.1 and Method 1103 (U.S EPA, 2000), and standard method SM 
9222D [American Public Health Association APHA 1998].  Dilutions of each water sample (100, 
10-1, 10-2, and 10-3) were prepared, and 10 mL of each dilution, as well as 10 mL and 100 mL of
each original sample, was filtered through 0.45um (cut size), 47 mm (diameter size) mixed 
cellulose ester filters (Millipore, Billerica, MA).   Each filter was placed on Enterococcus Agar 
(EA) and XLT4 Agar for the isolation of Enterococcus spp. and Salmonella spp., respectively.  
Throughout the water membrane filtration method, negative control filters w re employed for 
quality control and assurance.  All water sample filters were incubated at 41°C for Enterococcus 
and 37°C for Salmonella for 24 hr. Presumptive colonies  of Enterococcus ranged in appearance 
from brown to black with a brown-black precipitate on EA agar.  Similarly, colony morphology 
for presumptive Salmonella spp. was indicative of black colonies associated with a yellow color
change on XLT4 agar.  Enumeration of resulting colonies and concentratio s of Enterococcus 
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spp. and Salmonella spp. per 100 mL water were ascertained using back calculations fr m 
dilution plates containing 30-300 CFU.  Of recovered presumptive Enterococcus spp. and 
Salmonella spp., three bacterial isolates per water sample were archived in Brucella broth with 
20% glycerol at -80°C. 
 
B. Isolation of Enterococcus spp. From Poultry Litter and Poultry Feed 
Samples 
 
Poultry litter and feed samples were enriched in a 1:10 weight to volume dilution of 100 
mL of Enterococcosel Broth for 24 hr at 41°C.  Positive and negative control broths were 
included in this experiment for quality control and assurance.  After 24 hr, 10 uL of the 
enrichment culture was streaked onto Enterococcosel Agar (EA) and incubated overnight at 
41°C.  A single positive colony was streaked onto Brain Heart Infusion (BHI) agar, a non-
selective media, for purification of presumptive Enterococcus isolates and incubated at 41°C for 
24 hr. A substantial colony swab was collected from each BHI agar purification plate and 
archived at -80 °C in Brucella broth with 20% glycerol.   
 
C.  Isolation of Salmonella spp. From Poultry Litter and Feed      Samples 
 
 Salmonella spp. were recovered from poultry litter and feed samples using a two-step 
enrichment process.  Initially, litter and feed samples were pre-en iched in a 1:10 weight to 
volume dilution of 100 mL of Lactose Broth for 24 hr at 37°C.   From the Lactose Broth 
suspension, an aliquot (1mL) of the suspension was added to 15 mL of Hajna Tetrathionate 
Broth supplemented with a prepared iodine solution (1.2 mL per 15mL of Hajna) nd incubated 
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overnight at 37°C. Control (positive and negative) broths and agar plates wer  included for 
quality control and assurance.  After 24 hr, 10 uL of enrichment culture was streaked onto XLT4 
Agar and incubated at 37°C overnight for the isolation of Salmonella spp.   For samples that 
were initially Salmonella-negative using this method, a secondary enrichment-recovery was 
executed which entailed leaving the TT Hajna enrichment on the bench top for an additional 4-5 
days and subsequently streaking a loopful of the suspensions onto XLT4 agar pl tes.   After 
which, a single positive colony was streaked onto Brain Heart Infusion (BHI) agar, a non-
selective media, for purification of presumptive Salmonella isolates and incubated at 37°C for 24 
hr.   A generous swab of colonies was collected from each BHI agar purification plate and 
archived at -80 °C in Brucella broth with 20% glycerol.   
 
V. IDENTIFICATION  
 
 
A. Identification of Enterococcus Recovered from Water, Poultry Litter and 
Poultry Feed Samples 
 
Briefly, all presumptive Enterococcus isolates were streaked from archival stocks onto 
Blood Agar Plates and incubated at 41°C for 24 hr.  For presumptive identification of  
Enterococcus spp. from water, poultry litter and feed samples, a biochemical screening process 
(in order of method) was employed: gram staining for appearance of gram-positive cocci; 
catalase test for the production of catalase in the presence of 3% hydrogen peroxide;  and PYR 
testing for the enzymatic activity of pyrolidonyl-arylamidase (PYRase).   All gram-positive, 
catalase negative, and PYR test positive isolates were confirmed and identified to the species-
level using the automated biochemical identification Vitek ® System (Vitek ®Compact 2; 
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BioMérieux Vitek Systems Inc., Hazelwood, MO) in accordance with the manufacturer’s 
specifications.  Vitek 2 Compact Gram-Positive (GP) colorimetric cards were utilized for the 
interpretation of a suite of  biochemical screening tests appropriate for Enterococcus pp.   
 
 
B. Identification of Salmonella  Recovered from Water, Poultry Litter and 
Poultry Feed Samples  
 
 Briefly, all presumptive Salmonella isolates were streaked from archival stocks onto 
Blood Agar Plates and incubated at 37°C for 24 hr.  The biochemical screening tests performed 
on presumptive Salmonella spp. recovered from poultry litter, water and feed samples included 
(in order of method) Gram Staining, the oxidase test, the Lysine Iro  Agar (LIA) test, and the 
Triple Sugar Iron Agar (TSI) test.   All gram-negative, oxidase positive, LIA positive (alkaline 
slant: alkaline butt) and TSI positive (alkaline slant: acid butt) isolates as described by the FDA 
Bacteriological Analytical Manual (http://www.cfsan.fda.gov/~ebam/bam-5.html#Id) were 
presumptively identified as Salmonella.  Positive cultures were confirmed using the automated 
biochemical identification Vitek ®System (Vitek ®Compact 2; bioMérieux Vitek Systems Inc., 
Hazelwood, MO) by the manufacturer’s guidance. Vitek 2 Compact Gram-Negative (GN) 
colorimetric cards were utilized for the interpretation of a suite of biochemical screening tests 
appropriate for genus-level identification of Salmonella spp.  For speciation, Salmonella spp. 
were identified utilizing serological methods described in the FDA Center for Veterinary 
Medicine Food and Animal Microbiology Laboratory Standard Operating Procedures (530-058 
R-1): Serology of Salmonella Spp. Isolates u ing CDC antisera and Difco antisera (Becton 




VI.  ANTIMICROBIAL SUSCEPTIBILITY TESTING  
 
 
Antimicrobial susceptibility testing was performed on all Enterococcus (n=394) and 
Salmonella (n=121) isolates.   As depicted in Figure 1,  antimicrobial minimal inhibitory 
concentration (MIC) values for Enterococcus and Salmonella isolates were determined using the  
automated Sensititre™ antimicrobial susceptibility testing system (Trek Diagnostic Systems, 
Westlake, Ohio) according to the manufacturer’s directions.   A 0.5 McFarland Standard was 
placed into a nephelometer for calibration.  Colonies from pure 18-24hr cultu es were transferred 
to sterile Sensititre demineralized water.  50 µL of suspension (Enterococcus) and 30 µL of 
suspension (Salmonella) were  added to sterile of Sensititre cation-adjusted Mueller Hinton 
broth.  Briefly, an approximate 5 X 105 CFU/mL inoculum of each isolate was prepared from a 
Mueller-Hinton broth suspension to achieve a turbidity equivalent to a 0.5 McFarland standard.  
The final inoculate (50uL)  was dispensed into microtitre 96-well plates embedded with test 
antimicrobials.  Plates were incubated in the Automated Reading  and Incubation System (ARIS) 
at 37°C for 18 ± 1hr.   The first 100 plates were read both manually and vi  the ARIS system for 
quality assurance comparisons of MIC determinations; subsequent sample were read by ARIS 
exclusively.  
  Sensititre susceptibility testing was performed with the following antibiotics: 
(Enterococcus spp.) chloramphenicol, ciprofloxacin, daptomycin, erythromycin, flavomycin, 
gentamicin, kanamycin, lincomycin, linezolid, nitrofurantoin, penicillin, streptomycin, 
quinupristin/dalfopristin, tetracycline, tigecycline, tylosin, and vancomycin; and (Salmonella 
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spp.) amikacin, augmentin, ampicillin, cefoxitin, ceftiofur, ceftriaxone, chloramphenicol, 
ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfisoxazole, tetracycline, 
and trimethoprim-sulfamethoxazole.   In accordance with Clinical and Laboratory Standards 
Institute (CLSI) guidelines for broth- microdilution methods (www.clsi org;M31-A3), 
interpretation criteria were used to evaluate resulting MICs.   Enterococcus faecalis ATCC 
29212 and ATCC 51299, Staphylococcus aureus ATCC 29213, and Pseudomonas aeruginosa 
ATCC 27853 were used as quality control strains in antimicrobial MIC determinations.  
Inconclusive and indefinable ARIS system readings for MIC results were repeated. 
 
VII. STATISTICAL ANALYSIS 
 
 Enterococcus spp. (n=260) and Salmonella spp. (n=121) recovered from all positive 
poultry farm samples were included in the statistical analysis.  General linear latent and mixed 
models (GLLAMM) were used to evaluate associations between rates of antibiotic-resistant 
Enterococcus spp. and Salmonella spp. and on-farm environmental factors, including poultry 
production type (i.e. conventional or organic-transitioning).  The GLLAMM method was used to 
account for the clustered nature of the study design which made it necessary to adjust for intra-
poultry house and intra-poultry farm variability.  Within the GLLAMM framework, 
environmental factors were individually modeled against the suite antibiotic resistance data for 
Enterococcus spp. (gram-positive) and Salmonella spp. (gram-negative). A step-wise 
construction of antibiotic-specific models incorporating multiple significant environmental 
variables was employed yielding consideration to potential collinearity between variables.   
Subsequently, odds ratio were determined to compare the odds of  antibiotic resistance between 
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production types integrating selected environmental factors.   All statistical analyses were 
performed using STATA10 (Stata Corporation, College Station, TX) and in all cases, p values < 











Chapter 4: Results 
I.  POULTRY HOUSE CHARACTERISTICS 
Table 5 summarizes descriptive data concerning poultry house characteristics, 
meteorological conditions, and broiler information surveyed in organic-transitioning (n=10) and 
conventional (n=10) poultry operations in the Mid-Atlantic United States from March 31, 2008 
to June 2, 2008.  Organic-transitioning poultry houses, on average, were characterized by a 
seven-year house age difference compared with conventional counterparts. At the  time of 
sampling, average duration of organic-transitioning practices in poultry houses was 1.7 months. 
Comparatively, conventional poultry houses exhibited higher mean values for several 
meteorological and environmental parameters including inside temperature, inside humidity, and 
water activity.  Conventional poultry houses were characterized by an average of 8,250  
additional broilers/house, and broilers that were an average of 0.3 weeks older than organic-
transitioning poultry house equivalents.  Organic-transitioning poultry houses demonstrated 
structural differences from conventional houses.   Average length, width and ambient light of 
organic-transitioning poultry houses were greater than that of the conventional group.  The mean 
mortality rate was 4.7% in organic poultry houses compared to 2.56% in conventional houses.  
Neither organic-transitioning nor conventional poultry houses documented tim  outdoors for 





II.   ENTEROCOCCUS 
A. Prevalence of Enterococcus spp. 
 Enterococcus spp. were isolated from every organic-transitioning and conventional 
poultry farm tested during this baseline sampling period.   In enviro mental samples recovered 
from conventional and organic poultry production house environments, the prevalence of 
Enterococcus pp. was 100%.   The prevalence of Enterococcus pecies was prominent across all 
environmental media.  Interestingly, 60 percent of the waterline samples in conventional poultry 
houses were  Enterococcus spp. positive compared to 30% in organic-transitioning settings.   In 
this study, the predominant environmental media for the recovery of Enterococcus spp. isolates 
between both production types was poultry litter with similar distribution across litter sample 
location (Table 6).    
 The predominant Enterococcus species from all environmental samples, constituting 
approximately 50.4% of total isolated Enterococcus spp., was E. faecium (Table 7).  Within each 
type of production practice, the most common species isolated was E. f ecalis (50%) in organic-
transitioning and E. faecium (52%) in conventional production (Table 7).   Organic-transitioning 
poultry houses reveal greater species diversity among Enterococcus spp. (Table 7).  As presented 
in Table 8, a broad distribution of Enterococcus species was evident in a variety of 
environmental media sampled.  In conventional settings, E. faecium was the predominant species 
isolated from every environmental media sample except poultry source water.  Ninety-three 
percent of poultry waterline isolates from conventional poultry houses wereE. faecium (Table 
8).   Conventional poultry houses demonstrated greater Enterococcus species diversity within 
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poultry feed samples.  With respect to organic-transitioning production environments, E. faecalis 
was isolated solely from within poultry litter samples (Table 8).  Of the total environmental 
isolates, the non-Enterococcus spp. recovered were the following: thirty-two (11%) isolates were 
identified as Staphylococcus pp., 3 (1%) isolates were Pedioccocus spp. and 4 (1.35%) isolates 
were unidentified. 
B. Antibiotic Resistance of Enterococcus spp.: Minimal inhibitory 
concentration (MIC) distributions  
 
Classified by production type, the MIC distributions of Enterococcus spp. are 
summarized in Table 9.  Overall, all Enterococcus spp. isolates from conventional and organic-
transitioning poultry houses displayed similar ranges of MICs.   Five (36%) antimicrobial agents 
associated with conventional settings had wider MIC ranges than organic-transitioning 
Enterococcus isolates.  Conventional poultry houses were characterized by a greater number of 
isolates expressing the highest MICs.  Inter-species differenc s were evident among E. faecalis 
and E. faecium MICs associated with the different types of poultry houses (Table 10 & Table 
11).  Conventional E. faecium isolates expressed a wider range of MICs and a greater number of 
isolates at the uppermost MIC compared to E. faecalis isolates.   For example, conventional E. 






C. Antibiotic Resistance of Enterococcus spp.:  Resistance Patterns 
Conventional Enterococcus spp. isolates expressed resistance to a higher number of 
antibiotics compared to organic-transitioning isolates (Figure 8).  In general, intermediate 
resistance to a greater number of antibiotics was more common ag organic-transitioning 
Enterococcus isolates as shown in Figure 9.   Conventional Enterococcus isolates displayed 
overall higher percentages of resistance to across 83% (14/17) of antibiotic agents compared to 
organic isolates (Figure 10).   
Statistically significant differences were evident between production types for 9 out of 14 
antibiotics tested with isolates recovered from conventional poultry houses expressing elevated 
percent resistance compared to organic poultry houses (Table 17) 
  None of the organic-transitioning Enterococcus isolates expressed resistance to 
chloramphenicol, gentamicin, linezolid, and tigecycline.   In terms of both organic-transitioning 
and conventional poultry houses, all isolates displayed susceptibility to dap mycin, flavomycin, 
and vancomycin.  Similar antibiotic resistance patterns were evident for erythromycin and 
tylosin, which are both constituents of the macrolide antibiotic class.  Within poultry production 
type, several Enterococcus spp. expressed multi-drug resistance.   Over a third of Enterococcus 
isolated from conventional poultry environments (37%) were resistant to at least three 
antimicrobial classes compared to 10.3% of Enterococcus isolates in organic-transitioning 
settings in this study.  Relative to organic-transitioning poultry houses, E. faecium isolates from 
conventional houses expressed elevated levels of percent antibiotic resistance (Figure 11).  The 
most prominent differences occurred with penicillin (2.38% vs. 52.86%) (p ≤ 0.05) and 
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tetracycline (11.90% vs. 81.43%) (p ≤ 0.05).  As illustrated in Figure 12, E. faecalis isolates 
from conventional broiler production expressed higher resistance to the majority of antibiotics 
tested except for tetracycline.  Due to intrinsic resistance, both organic-transitioning and 
conventional E. faecalis isolates expressed complete antibiotic resistance to lincomycin and 
similar rates of resistance for Synercid, a human analog of virginiamycin.   In addition, the 
Pediococcus spp. (n=3) isolated from feed samples were resistant to vancomycin, an intrinsic 
trait of that species.  
III. SALMONELLA. 
A. Prevalence of Salmonella spp. 
During this baseline sampling period, the prevalence of Salmonella spp.  on organic-
transitioning and conventional poultry farms in this study was 100% and 40%, respectively.  
Salmonella spp. were isolated from several organic-transitioning (n=8) and conventional poultry 
houses (n=3).  The prevalence of Salmonella within organic poultry houses in this study was 
80% compared to 30% in conventional poultry houses.   In this study, the predominant 
environmental media for the recovery of Salmonella spp. isolates was poultry litter 2 (under 
waterline) in organic-transitioning poultry houses and poultry feed in co ventional poultry 
houses (Table 11). 
An array of Salmonella serovars were identified from both conventional and organic-
transitioning poultry houses (Table 12).   S. kentucky was the predominant serovar; accounting 
for 63% of total Salmonella spp. isolates (Table 13).   Salmonella spp. were present in three 
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types of environmental media (poultry litter, feed and soil) recovered from conventional poultry 
houses; however, Salmonella was only found in poultry litter collected from organic-
transitioning poultry houses (Table 14).  Of conventional poultry houses isolates, S. kentucky was 
exclusively isolated from poultry litter.  Of the total environmental isolates, the non-Salmonella 
spp. recovered were the following: three (2.7%) isolates were identif ed as Escherichia coli e 
coli, 1 (.9%) isolate was lactose-fermenting E. coli, 3 (2.7%) were Pseudomonas luteola isolates, 
and 3(2.7%) isolates were Citrobacter freundi. 
B. Antibiotic Resistance of Salmonella spp.: MIC Distributions 
MIC distributions of Salmonella spp. categorized by production type are presented in 
Table (Table 15).  On the whole, organic-transitioning poultry houses consiste tly displayed a 
higher number of isolates within the lower concentration range of the MIC distribution for all 
antibiotics tested.  Conventional poultry houses displayed a higher number of isolates within the 
upper concentration range of the MIC distribution for augmentin, ampicillin, and ceftriaxone.  
Consistently, conventional and organic-transitioning poultry houses displayed analogous ranges 
of MICs for all Salmonella spp. isolates.  Five (33%) antimicrobial agents associated with 
organic-transitioning production environments had wider MIC ranges for Salmonella isolates 
than those recovered from conventional settings.  
C. Antibiotic Resistance of Salmonella spp.: Resistance Patterns 
Conventional and organic-transitioning Salmonella spp. isolates exhibited resistance to a 
similar suite of antibiotics.  (Figure 13).  Intermediate resistance to a higher number of 
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antibiotics was more common among organic-transitioning Salmonella spp. isolates (Figure 14). 
Conventional Salmonella spp. isolates displayed a higher percent resistance compared to organic 
isolates for augmentin, ampicillin, cefoxitin, and ceftiofur (Figure 15).   Among the 
aforementioned antibiotics, there were no significant differences between production types. 
Similar antibiotic resistance patterns were observed for streptomycin and tetracycline, members 
of the aminoglycoside and tetracycline antibiotic classes, respectively.   In addition, there were 
no significant differences in resistance to these antibiotics between isolates from conventional 
and organic-transitioning poultry houses (Table 15).   None of the Salmonella spp. isolates 
expressed resistance to amikacin, ceftriaxone, chloramphenicol, ciprofloxacin, gentamicin, 
nalidixic acid, sulfisoxazole, and trimethoprim/sulfamethoxazone antimicrobial agents.  Within 
both production types, only S. kentucky isolates expressed resistance to any particular antibiotic 
with remaining serovars being susceptible to all antimicrobials tested (Figure 16).   Multi-drug-
resistant Salmonella spp. isolates also were prevalent in this baseline study (Table 16).   Sixty-
two percent of organic-transitioning S.  kentucky isolates were resistant to at least 2 
antimicrobials, and 21% of conventional S. Kentucky were resistant to at least 2 antimicrobials.  
Of highlight, 21% of 24 conventional S. kentucky isolates were resistant to 6 antimicrobials 
tested compared to 4% of organic isolates.  
IV. ENVIRONMENTAL FACTORS 
 Percent resistance to all antibiotics was compared between conventi al and organic-
transitioning houses using the GLLAMM model.  Several environmental variables were also 
modeled using GLLAMM to determine whether associations existed between environmental 
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factors within the poultry production environment and the prevalence of antibiotic-resistant 
Enterococcus pp. and Salmonella spp..  
A. Enterococcus 
Enterococcus spp. p-values were compared in association with individual environmental 
variables in conventional and organic-transitioning poultry house adjusting for intra-poultry 
house and farm variation modeled across the suite of tested antibiotics.   In tandem, collinearity 
was examined between selected environmental factors prior to incorporation into antibiotic-
specific multivariate model using GLLAMM with highly collinear variables (>0.5) excised from 
the model (Table 17).  Only streptomycin (STR) resistance was st tistically significantly 
different between conventional and organic-transitioning poultry houses in association with any 
environmental factors modeled using GLLAMM when adjusted for intra-poultry house and-farm 
variation.  Humidity inside of the poultry houses was successfully model fit with significant STR 
resistance differences between production systems.  In our study, there is a 2.7 times more likely 
odds of STR resistant Enterococcus isolates recovered from conventional poultry houses 
compared to organic-transitioning poultry houses (95% CI =[1.2 ,6.0]; P<0.017), after 
controlling for humidity inside the house.   In addition for every unit increase in humidity the 
odds of STR resistance in Enterococcus isolates within conventional poultry houses decreases by 






There was  no  statistically significant difference in  expr ssed resistance to a particular 
antibiotic between conventional and organic-transitioning poultry houses acro s the entire suite 
of tested antibiotics.  Therefore, analysis of the influence of nvironmental variables and odds 
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Chapter 5: Discussion and Conclusions 
I. DISCUSSION 
In this baseline study, antibiotic-resistant Enterococcus and Salmonella were isolated 
from conventional and organic-transitioning poultry farms.  This is the first epidemiological on-
farm study in United States to investigate temporal trends in antibiotic resistance of Salmonella 
spp. and Enterococcus spp. recovered from poultry farms undergoing conversion to organic 
practices and discontinuing the use of GPAs.   Moreover, this study is novel in the examination 
of potential environmental risk factors for antibiotic resistance in conventional and organic-
transitioning poultry farms.   
Overall, results confirm differences in prevalence and antimicrobial susceptibility of 
Enterococcus and Salmonella spp. recovered from conventional versus organic-transitioning 
poultry production systems.  Specific findings indicate that there is an elevated prevalence of 
Enterococcus spp. in samples recovered from conventional poultry production environments and 
a greater percentage of these isolates are resistant to a suite of antibiotics compared to isolates 
recovered from organic-transitioning poultry environments (Table and Figure 10).  As depicted 
in Table 12, there was a higher prevalence of Salmonella isolates recovered from organic-
transitioning poultry houses during time of sampling.  Two major antibiotic resistant patterns 
emerged from examination of Salmonella isolates obtained from differing broiler production 
systems (Figure 15).  Members of the β-lactams and cephems antimicrobial class exhibited 
higher percentage of resistance in organic-transitioning poultry houses than conventional poultry 
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house complements(Table and Figure 15).  There were no Enterococcus isolates resistant to 
daptomycin, flavomycin or vancomycin.  This result makes sense because v ncomycin was 
never approved for use in poultry production in the United States (USDA, 2001).  In addition, 
there were no statistically significant differences in antibio c resistance between production 
types for older generation antibiotics such as lincomycin (with regard to Enterococcus isolates) 
and streptomycin and tetracycline (with regard to Salmonella isolates).   
Because this was a baseline study, our purpose was to examine prelminary prevalence 
and antibiotic resistance of Enterococcus spp. and Salmonella spp. by production type within the 
first-year of the study.  As the foundation for a 4-year long-term study, our investigation did not 
anticipate significant differences for a majority of antibiotics tested due in part to the initial stage 
of the study.  In capturing the most accurate measure of the epidemiological intervention on 
production practices within poultry environments, study sampling commenced at the earliest 
point of conversion.  The lion’s share of organic-transitioning farms (the intervention group) had 
only recently undergone conversion--on average, they had converted within the previous 2 
months before initial sampling.  Intuitively, it is most probable that t e organic-transitioning 
poultry houses more mirrored conventional counterparts and thus significant d fferences between 
production types would not be as apparent at time of sampling.  This is a viable justification for 
the low prevalence and absence of significant resistance pattern differences between production 
types for Enterococcus spp. and, in particular the  majority of Salmonella spp., isolated in this 
study.  To this end, an explanation for the lack of associations between environmental factors 




In environmental samples collected from conventional and organic-transitioning poultry 
farms, the prevalence of Enterococcus was 100%.  Enterococcus faecium  proved to be a 
pervasive organism across the majority of environmental media.  The results indicate higher 
levels species diversity observed in organic-transitioning poultry houses.   As the organic-
transitioning poultry houses do not utilize antibiotics across any aspect of the production 
continuum, it is probable that a more diverse population of Enterococcus spp. could be 
established due to the absence of selection pressures associated with antibiotics which can 
normally displace susceptible Enterococcus species.  The results indicate a statistically 
significant difference between poultry production systems for Enterococcus resistance to a 
majority of the antibiotics tested in the direction of conventional poultry production.  These 
findings are in agreement with cross-sectional studies comparing conventional and a variety of 
poultry production practices along the organic certification spectrum where data reveals higher 
percentages of antibiotic-resistant bacteria on conventional poultry farms and conventional 
poultry products.   In a one-year cross-sectional study of conventional and organic poultry 
houses, findings from  Joseph et al, 2006 indicated that the percentage of E. faecium resistant to 
nine different classes of antibiotics was statistically significantly higher among isolates 
recovered from conventional poultry houses compared to  organic poultry houses.  More 
specifically, 98% of E. faecium from conventional poultry houses were resistant to erythromycin, 
compared to 43% of isolates recovered from organic poultry houses (OR=50.9, 95% CI = 22.1-
134.4) (Joseph et al. 2006).  Similarly  a study conducted by Price et al (2005) which compared 
fluoroquinolone-resistant Campylobacter spp. on conventional versus antibiotic-free poultry 
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products found conventional products had statistically significantly higher odds of carrying 
resistant isolates compared to antibiotic-free products. 
B. Salmonella 
There was a more striking contrast in Salmonella prevalence between samples originating 
from conventional versus organic-transitioning poultry farms, with samples from organic-
transitioning farms characterized by an approximately 2.5-fold higher prevalence of Salmonella 
spp.  These findings are generally consistent with previous studies that have observed higher 
loads of Salmonella in organic poultry farms and products compared to conventional 
counterparts (Cui et al., 2005; Miranda et al., 2007; Van et al., 2006).  An explanation for 
increased prevalence of Salmonella in organic settings has been hypothesized to involve contact 
with  potential environmental reservoirs of Salmonella infections.  As mandated with the organic 
certification process for poultry production, organic farms must afford poultry flock access to the 
outside environment.   Piekus (2008) theorizes, outdoor access may increase th  risk of 
Salmonella infection via contact with feces of wild birds or other animals near organic poultry 
production facilities.  Some of the major animal reservoirs include cats, dogs, opossums, rodents, 
raccoons, badgers, chipmunks, and skunks via fecal shedding (Jacob, Griggs, & Bender 2008).  
Specifically, mice represent a perpetual source of Salmonella, principally, S. enteritidis (Davies 
& Wray, 1996).  However, in our study poultry growers reported that the organic-transitioning 
broilers never roamed outside even when provided access to an outdoor area; indicating that 
biological vectors presumably did not play a role in Salmonella prevalence in organic-
transitioning poultry houses.    
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 The predominant serovar of Salmonella found in both types of production environments 
was S. Kentucky which was also the only serovar to express resistance to a particular antibiotic. 
Interestingly, feed contamination via  Salmonella species was prevalent in conventional poultry 
houses in this study, exclusively.  Historically, there has been dir cted inference that formulated 
feeds are principal contributors in the introduction of resistant food-borne bacteria (Levy, 1998) 
in agricultural settings.  However, the organic-transitioning poultry houses which discontinued 
use of GAPs, expressed antibiotic-resistance for several  Salmonella spp. isolates in this study. 
This study further provides evidence  in which other  environmental inputs co ld be potentially 
contributing to the prevalence  and antibiotic resistance of Salmonella spp. in poultry production 
environments.   
Production type played no significant role in percentages of antibiotic-res stant 
Salmonella.  Similar levels of antibiotic resistance in both organic and conventional poultry 
facilities have been observed in other gram-negative bacteria specie .  Luangtongkum et al. 
(2006) also observed high levels of tetracycline-resistant Campylobacter spp. among isolates 
from both organic and conventional poultry farms.  Upon reflection on the prepond rance of 
Salmonella multi-drug resistance in conventional poultry settings, our baseline data suggests 
differences in the expression of multi-drug resistance profiles based on production practices.  
These findings support evidence from Cui et al. (2005) which reported that 100% of Salmonella 
enterica serovar Typhimurium isolates recovered from conventional poultry products p rchased 
in Maryland grocery stores were resistant to at least 5 antimicrobials, while 79% of isolates 
recovered from organic poultry products were susceptible to 17 antimicrobials.  Likewise, Ray et 
al. (2006) observed  that conventional dairy farms tend to be more likely to have at least one 
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Salmonella isolate resistant to five or more antimicrobial agents when compared with organic 
farms. However, the small number of Salmonella spp. in this study does not permit a conclusive 
statement.  
C.  Environmental Factors on Antibiotic Resistance in Poultry Houses  
            A variety of environmental factors were examined to evaluate whether they impacted the 
prevalence of antibiotic-resistant bacteria in conventional and organic-tr sitioning poultry 
houses.  Inside humidity was statistically significantly associated with differences in prevalence 
of STR-resistant Enterococcus spp. between conventional and organic-transitioning poultry 
houses.  Humidity provides a suitable environment for bacterial growth in general, may 
contribute to  the spreading of bacterial contamination throughout poultry houses Coupled with 
the inherent genetic promiscuity of Enterococcus spp.,  elevated bacterial population levels may 
yield the opportunity for potential acquisition and proliferation of resid nt antibiotic resistant 
gene elements throughout the poultry production environment.   However, a  biologically 
plausible explanation for an association between humidity and  the decr as  in antibiotic 
resistance of Streptomycin can be ascribed to thermal stress.  A threshold response to thermal 
stress associated with increased humidity  could contribute to reversion of resistant bacteria to 
susceptible wild-type over considerable time.  Further research is warranted to investigate a more 
conclusive interpretation. 
 
At the time of sampling, statistically significant differenc s in antibiotic resistance were 
not evident for Salmonella spp. between conventional and organic-transitioning poultry houses.  
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This finding is not surprising due to the time of sampling and the baseline stage of the 
longitudinal study.  Sampling was performed at the beginning of flock introduction within the 
poultry houses which may impact the dynamics of antibiotic resistance and influence of 
environmental factors on resistance.  As to provide the most accurate baseline data, the organic-
transitioning poultry houses were chosen at the genesis of their conversion to organic practices.   
Poultry houses in the organic-transitioning (intervention) group were, on average, 3 months 
removed from the practices associated with conventional poultry farms.  Therefore, significant 
differences between production types based on the adoption of organic prctices would be 
seemingly premature and inconsistent with previous studies.  Several studies have documented 
differences in antibiotic resistance and prevalence of bacteria over a more extended time-span. 
For example, Aarestrup (2001) revealed a 14-fold decrease in the prevalence of glycopeptide-
resistant E .faecium in broilers following a 1995 Danish avoparcin ban, after a five-year time 
period (72.7% in 1995 to 5.8% in 2000).   
 
II.   LIMITATIONS  
This baseline study had several major limitations which are inhere t in epidemiological 
research and artifacts of preliminary data collection.  Firstly, the study is limited by geographical 
location in that all poultry farms were located in the Mid-Atlan ic United States.  However, 
poultry products produced in this area are widely distributed in the Unit d States; therefore, the 
limited geographical locations covered in this study would not likely affect the generalizability 
of the results.  Secondly, recovery of Salmonella across all environmental samples was 
potentially limited by our  isolation techniques.  Some studies have shown that a Rappaport- 
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Vassiliadis (RV) enrichment protocol may be more effective in isolating Salmonella, i.e. water 
samples, compared to TT-Hajna enrichment protocol that we used.  This may have been why we 
isolated a relatively low number of Salmonella compared to Enterococcus.  In addition, we were 
not able to capture on-farm levels of pH in environmental media which may play a significant 
role in the prevalence of bacterial organisms since  pH is a limiting factor for bacterial growth. 
Thirdly, the short sampling period proved to be a hindrance in analyzig environmental 
associations  over time, including the potential effect of seasonal variation.  Seasonal variation 
will be adjusted for with subsequent sampling seasons during the ensuing 4-year study.  Lastly, 
sample independence was an issue in this study because samples were clustered due to the 
collection of multiple environmental samples within the same poultry house and the same 
poultry farm.  The selection of the GLLAMM for binary outcomes was chosen to adjust for 
intra-poultry house and intra-poultry farm variation between sample isolates recovered in the 
study.   
 
III.  PUBLIC HEALTH IMPLICATIONS  
Within the industrial farm animal production complex, the use of GPAs in food-animal 
production could present a potential human health concern with regard to exposures t antibiotic-
resistant bacteria and; thereby, significantly compromise the fficacy of the arsenal of antibiotics 
utilized for treatment of clinical infections in the United States.  By way of a recent declaration 
by the  Infectious Disease Society of America (ISDA),infections associated with antibiotic 
resistance have been deemed as a public health “epidemic” in the United States (Spellberg et al., 
2008).  Direct epidemiological analyses relay that antimicrobial-resistant bacteria populations 
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derived from food animals can be transmitted to human populations (van den Bogaard, 2000; 
Angulo, Nagrund & Chiller, 2004).  Presently, the emergence and persistence of antibiotic 
resistance in pathogenic and commensal food-borne bacteria, including Campylobacter spp., 
Salmonella spp. and Enterococcus spp. endangers individual human health, as well as the public 
health infrastructure (Altekruse, 1999; Heuer, 2006; IOM, 1998; Molbak, 2005).  Conservative 
estimates suggest that the attributable fraction of food-borne antibiotic- resistant non-typhoidal 
Salmonella spp. and. infections from food animals is 2.6%, (Barza, 2002).   Specifically, there is 
evidence that the use of antimicrobials, specifically GPAs, in poultry production could be a 
contributor to the development of antibiotic resistance in pathogenic and ommensal food-borne 
bacteria (Gorbach, 2001; Idris, 2006; NRC, 1999; Wegener, 2003).  Internationally, a number of 
studies have explored the role of poultry production in the rise of antibiotic-resistant bacteria 
(Wegener, 1999; Heuer, 2001; Bywater, 2004).  EU countries, in response to this potential public 
health threat, banned four growth promoters (bacitracin, tylosin, spiramycin, and virginiamycin) 
in 1998 due to structure and mechanistic relatedness to human antibiotic equival nts (EU 
Commission, 2003). 
From a public-health perspective, our specific study demonstrate  the effectiveness of an 
intervention initiative promoting the cessation of antibiotic use within poultry production 
environments.  Organic-transitioning, as characterized by the discontinuation of antibiotic use, 
may lead to significant reductions in antibiotic-resistance in poultry environment over time.  We 
observed nascent reductions in antibiotic resistance of selected food-borne bacteria in association 
with production practice conversion.  Subsequently, the alteration of production operations may 
lead to lower  risks associated with exposure  to resistant food-borne bacteria either directly 
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(contact with food-animals) or indirectly (consumption of foodstuffs contaminated with resistant 
food-borne bacteria) in connection to poultry production.  This baseline  study  generates a 
primary scientific source for a  U.S. scenario involving the  complete abolishment of  antibiotics 
of public health importance in food animal production.  The outcome of this study could prove 
very timely and influential within the national political landscape.  On March 17, 2009, 
Congresswoman Louise M. Slaughter and Senator Edward Kennedy introduced a bill to curtail 
excessive usage of antibiotics in the Nation’s food supply by advocating the phase out of 
antibiotic formulations utilized in both human and veterinary medicine in food animal 
production.  The legislation, Preservation of Antibiotics for Medical Treatment Act (H.R. 
1549/S. 619), would be enacted to:  
 a. Phase out the non-therapeutic use in livestock of medically important 
 antibiotics; 
 
 b. Require this same tough standard of new applications for approval of   
 antibiotics; 
 
 c. Provisions for the therapeutic use of antibiotics in the treatment of sick 
 animals, treat pets and other animals not used for food 
 consumption.(GovTrak, 2009) 
 
 The PAMTA would prove to be a monumental step in the fight against antibiotic 
resistance in clinical infections.  Ultimately, the analysis from this longitudinal study examining 
the organic-transition process may provide vital scientific knowledge to undergird such 
legislative action and spur necessary change in U.S.  public heath policy regarding antibiotic use 







 In summation, the results of this baseline study confirm the prevalence and current levels 
of susceptible and antibiotic resistant Enterococcus pp. and Salmonella spp. in conventional and 
organic-transitioning poultry farm environments. These findings suggest that production 
management practices may play a role in the prevalence and antibiotic resistance of selected 
bacterial species within differing poultry production operations.  In addition, the influence of 
environmental factors within the environmental-microbial-resistance paradigm was explored 
with respect to production practice.  Our study findings demonstrate the initial effects of an 
ecosystem-level intervention to reduce the prevalence of antimicrobial resistance in food-borne 
bacteria derived from farm environments via modification in production practice.  In addition, 
this baseline study establishes the foundation for future comparative work examining antibiotic 
resistance in differing poultry production environments over time.   To conclude,  this on-farm 
intervention study will contribute to the growing body of knowledge in examining the food-
borne bacteria and antibiotic resistance patterns in food animal production environments as a 












Table 1: Clinical and Laboratory Standards Institute Interpr tative Criteria for 
MIC determinations of Enterococcus pp. and Salmonella spp. 
 










      
Aminoglycosides      
  AmikacinS  0.25-64 ≥32 
  GentamicinE  64-2048 ≥500 
  GentamicinS  0.125-16 ≥16 
  KanamycinE  64-2048 ≥512 
  KanamycinS  64-2048 ≥64 
  StreptomycinE  256-2048 >1000 
  StreptomycinS  16-64 ≥64 
Bambermycin      
  FlavomycinS  0.5-32 >32 
B-lactam/ 
Blactamase inhibitors 




acid)S  0.5-32 ≥16 
  AmpicillinS  0.5-32 ≥32 
Cephems      
  CefoxtinS  0.25-32 ≥32 
  CeftiofurS  0.06-16 ≥8 





Table 1: (cont’d) 
 
 
Chloramphenicol      
  ChloramphenicolE  1-32 ≥32 
  ChloramphenicolS  1-32 ≥32 
Folate pathway inhibitors    
  Trimeth/sulfamethS  0.125-8 ≥4/76 
Glycylcyclines      
  TigecyclineE  0.015-0.05 ≥0.25
b 
Glycopeptides; glycopeptide    
  VancomycinE  0.25-32 ≥32 
Lincosamides      
  LincomycinE  0.05-32 ≥8 
Lipopeptides      
  DaptomycinE  0.25-16 ≥4b 
Macrolides      
  ErythromycinE  0.25-8 ≥8 
  TylosinE  0.125-32 ≥32 
Nitrofurans      
  NitrofurantoinE  1-64 ≥64 
Oxazolidinones      
  LinezolidE  0.25-8 ≥8 
Pencillins      
  PenicillinE  0.25-16 ≥16 
Streptogramins (combo)     
  Quinupristin/dalfopristinE 0.5-32 ≥4 
Sulfathiazole      
  SulfisoxazoleS  16-512 ≥512 
Tetracyclines      
  TetracyclineE  0.25-32 ≥16 






 Table 1: (cont’d) 
 
Quinolones      
  CiprofloxacinE  0.06-4 ≥4 
  CiprofloxacinS    
      
    Nalidixic AcidS   0.25-32 ≥32 
a All resistance breakpoints are those defined by CLSI unless otherwise noted. 
b For daptomycin and tigecycline, resistance breakpoint has not been established.  
   Report as non-susceptible.    
E Antimicrobial agents tested on Enterococcus pp.    
S Antimicrobial agents tested on Salmonella spp.    
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Source:  Adapted from Most Common Serotypes among Salmonella(non-Typhi) Isolates from 
Humans, Retail Meats, and Food Animals, 2005 














10 Paratyphi B1 
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Table 4: Selected antimicrobials approved by the FDA for use in broiler 
production   
 
Antibiotics Used in Poultry 
Labeled as a 
Growth 
Promoter 
Example of Human Drug 
Exhibiting Complete Cross-
resistance 
Aminoglycosides    
 
                                                      
Streptomycin No Kanamycin, Neomycin 
 Neomycin No Kanamycin 
 Gentamicin No None 
Aminocyclitols    
 Spectinomycin Yes None 
B-lactams    
 Penicillin Yes Ampicillin 
Decapeptides    
 Bacitracin Yes Bacitracin 
Fluoroquinolones    
 Enrofloxacin No Ciprofloxacin 
 Sarafloxacin No None 
Lincosamides    
 Lincomycin No Clindamycin 
Macrolides    
 Erythromycin No Clarithromycin,Azithromycin 
 Tylosin Yes Erythromycin 
Tetracyclines    
 Chlortetracycline Yes 
 
Oxytetracycline,Tetracycline, 
 Oxytetracycline No Chlortetracycline,Tetracycline 
 Tetracycline No 
Oxytetracycline, 
Chlortetracycline 
Streptogramins    
 Virginiamycin Yes Quinupristin/Dalfopristin 
Bambermycin  Yes None 
Novobiocin  No None 





Table 5:  Poultry House Demographics for study Conventional a d Organic-transitioning poultry  house 









Organic Months 1.71 0 1 0 3.55 0
Temperature (outside) 59.53 68.99 55 67 74 80
Temperature (inside) 68.27 73.38 68 73 75 77.5
Humidity (outside) 57.02 53.9 47.5 48 99.9 73.5
Humidity (inside) 68.6 69.5 68.5 69 90 89.5
Airflow 0.33 0.703 0.4 0.5 0.7 1.9
Water Activity (Aw) 0.829 0.838 0.85 0.855 0.965 0.95
Ambient Light, Fans on 7.26 7.1 3.575 5.53 16.7 13.41
Ambient Light, Fans off 2.23 . 1.93 . 3.1 .
Length of house 500 411 500 500 500 500
Width of house 46.8 44.6 48 44 48 50
Depth of poultry Litter 5.4 4.8 5 4 7 8
Months after litter changed 4 2.14 2.33 4 12 8
Number of chickens 22550 30800 24000 30800 24000 30800
Age of flock 35.8 36.1 35 36 40.5 40
Mortality rate 4.704 2.56 4.475 2.5 6.9 2.6







Table 6:  Enterococcus pp. isolated from water, poultry litter, and 
poultry feed samples collected from conventional and organic-
transitioning poultry farms 
   
Poultry House 
Type   
Environmental 
 Source 





     
CONVENTIONAL     
(n=134) 




















































      
  
Table 7: Distribution of Enterococcus pecies isolated from organic-
transitioning and conventional poultry production systems  
    
Poultry House 
Type    
 
Species      
Identification 





     






























































 Enterococcus hirae 12(4.62) 7(5.55) 5(3.73)  





Table 8: Distribution of Enterococcus pecies isolated from water, 
poultry litter, and poultry feed samples collected from conventional and 
organic-transitioning poultry farms 
Type of House   Species   
 E.durans E.faecalis E.faecium E.gallanarium E.hirae 
Conventional      
      
Poultry Litter 1 (n=29) 0 8(28.6) 20(68.5) 1(3.45) 0 
      
Poultry Litter 2 (n=31) 0 16(51.6) 15(48.38) 0 0 
      
Poultry Litter 3 (n=30) 0 10(33.3) 16(53.3) 1(3.33) 3(10) 
      
Poultry Feed (n=29) 0 10(34.5) 15(51.7) 1(3.45) 3(10.3) 
      
Water: Source (n=1) 1(100) 0 0 0 0 
      
Water: Waterline (n=13) 0 0 12(92.3) 0 1(7.69) 
      
Organic-
Transitioning      
      
Poultry Litter 1 (n=35) 0 20(57.1) 9(25.7) 4(11.4) 2(5.71) 
      
Poultry Litter 2 (n=30) 6(20) 16(53.3) 8(26.7) 0 0 
      
Poultry Litter 3 (n=30) 0 27(90) 1(3.33) 0 1(3.33) 
      
Poultry Feed (n=27) 1(3.57) 0 22(81.4) 0 4(14.3) 
      
Water: Source (n=1) 0 0 1(100) 0 0 
      










Table 9: Minimal inhibitory concentration (MIC) distributions (µg/ml) for 
17 antimicrobials among Enterococcus spp. (n=260) collected from 
conventional and organic-transitioning poultry farms 
Enterococcus spp. (n=260)
Antimicrobial Production MIC Range
 Agent Practice 0.015 0 0.1 0.1 0.3 0.5 1 2 4 8 16 32 64 128 256 5121024 2048 >2048 (ug/ml)
Conventional 0 61 69 2 2a 2-≥32
Organic-Transitioning 1b 31 89 5 0 2-16
Conventional 2 8 61 20 43a 0.25-≥4
Organic-Transitioning 3 14 53 41 13a 0.25-≥4
Conventional 11b 53 29 41 ≤0.5-4
Organic-Transitioning 11b 55 42 19 ≤0.5-4
Conventional 40b 19 16 8 51a ≤0.5-≥8
Organic-Transitioning 39b 28 23 14 20a ≤0.5-≥8
Conventional 2b 50 5 12 63a ≤1-≥16
Organic-Transitioning 31b 36 2 1 56a ≤1-≥16
Conventional 112b 5 5 12a ≤128-≥1024























63 63 2 1 ≤0.5-8
Organic-Transitioning 1
b
27 76 22 0 ≤0.5-4
G e n t a m i c i n
K a n a m y c i n
L i n c o m y c i n
L i n e z o l i d
No. of Isolates   MIC (ug/ml) of:
  C h l o r a m p h e n i c o l
C i p r o f l o a x c i n
D a p t o m y c i n
E r y t h r o m y c i n






Table 9: (cont’d) 
Enterococcus spp. (n=260)
Antimicrobial Production MIC Range
 Agent Practice 0.015 0 0.1 0.1 0.3 0.5 1 2 4 8 16 32 64 128 256 5121024 2048 >2048 (ug/ml)
Conventional 29 16 9 80
a
8-≥64










7 14 79 19 1 ≤0.5-≥16
Conventional 111
b
9 7 7 ≤512-≥2048
Organic-Transitioning 116
b
4 3 3 ≤512-≥2048
Conventional 11
b
18 73 21 6 5 ≤1-32
Organic-Transitioning 13
b











Conventional 2 31 58 36 7 0.03-0.5
Organic-Transitioning 4 26 49 47 0 0.03-0.25
Conventional 10 23 37 9 4 51
a
1-≥32





54 24 3 ≤0.5-4
Organic-Transitioning 31
b
66 24 5 ≤0.5-4
1  For daptomycin and tigecycline represents number non-susceptible
a Number of isolates with MICs gretater than or equal to the highest concentration on Sensititre plate
b Number of isolates with MICs less than or equal to the lowest tested concentration on Sensititre plate
No. of Isolates   MIC (ug/ml) of:
Q u i n u p r i s t i n/                           
D a l f o p r i s t i n                            
S t r e p t o m y c i n
T e t r a c y c l i n e
T i g e c y c l i n e 
T y l o s i n
V a n c o m y c i n
N i t r o f u r a n t o i n




Table 10: Minimal inhibitory concentration (MIC) distributions (µg/ml) for 
17 antimicrobials among Enterococcus faecalis (n=180) collected from 
conventional and organic-transitioning poultry farms 
 
Enterococcus faecalis (n=118) 
Antimicrobial Production MIC Range
 Agent Practice 0.015 0.03 0.06 0.13 0.25 0.5 1 2 4 8 16 32 64 128256 512 1024 2048>2048 (ug/ml)
Conventional 0 22 30 1 2a 4-≥32
Organic-
Transitioning 0 6 52 5 0 4-16
Conventional 0 3 44 5 3 0.5-4
Organic-
Transitioning 0 0 34 26 3a 1-≥4
Conventional 6b 45 0 4 ≤0.5-4
Organic-
Transitioning 2b 51 8 2 ≤0.5-4
Conventional 5b 5 8 0 37a ≤0.5-≥8
Organic-
Transitioning 17b 25 8 0 11a ≤0.5-≥8
Conventional 2b 46 1 1 5a ≤1-≥16
Organic-
Transitioning 31b 31 0 0 1a ≤1-≥16
Conventional 50b 0 1 4a ≤128-≥1024
Organic-
Transitioning 63b 0 0 0 128
Conventional 42b 1 0 12a ≤64-≥1024
Organic-
Transitioning 57b 1 0 5a ≤64-≥1024
Conventional 0 0 0 0 7 48a 1-≥32
Organic-
Transitioning 0 0 0 0 13 50a 1-≥32
Conventional 2b 42 11 0 0 ≤0.5-2
Organic-
Transitioning 0 11 39 13 0 1-4
G e n t a m i c i n
K a n a m y c i n
L i n c o m y c i n
L i n e z o l i d
No. of Isolates  by  MIC (ug/ml) of:
C h l o r a m p h e n i c o l
C i p r o f l o a x c i n
D a p t o m y c i n
E r y t h r o m y c i n
F l a v o m y c i n
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Table 10: (cont’d) 
 
Enterococcus faecalis (n=118) 
Antimicrobial Production MIC Range
 Agent Practice 0.015 0.03 0.06 0.13 0.25 0.5 1 2 4 8 16 32 64 128256 512 1024 2048>2048 (ug/ml)




Transitioning 24 20 4 15
a
8-≥64
Conventional 0 0 8 40 4 3a 2-≥16
Organic-
Transitioning 0 0 2 53 8 0 2-8
Conventional 38b 6 6 5 ≤512-≥2048
Organic-
Transitioning 56b 2 2 3 ≤512-≥2048
Conventional 0 1 37 10 5 2 2-64
Organic-
Transitioning 0 1 24 38 0 0 2-8
Conventional 2b 0 4 49a ≤4-≥32
Organic-
Transitioning 0 0 0 63a ≥32
Conventional 2 11 19 18 5 0.03-0.5
Organic-
Transitioning 0 11 18 34 0 0.06-0.25




Transitioning 3 22 22 3 0 13a 1-≥32
Conventional 2b 31 19 3 ≤0.5-4
Organic-
Transitioning 0 39 20 4 1-4
1  For daptomycin and tigecycline represents number non-susceptible
a Number of isolates with MICs gretater than or equal to the highest concentration on Sensititre plate
b Number of isolates with MICs less than or equal to the lowest tested concentration on Sensititre plate
V a n c o m y c i n
No. of Isolates   MIC (ug/ml) of:
S t r e p t o m y c i n
Q u i n u p r i s t i n
 D a l f o p r i s t i n
T e t r a c y c l i n e
T i g e c y c l i n e
T y l o s i n
N i t r o f u r a n t o i n







Table 11: Minimal inhibitory concentration (MIC) distributions (µg/ml) for 
17 antimicrobials among Enterococcus faecium (n=113) collected from 
conventional and organic-transitioning poultry farms 
 
 Enterococcus faecium (n=113) 
Antimicrobial Production MIC Range
 Agent Practice 0.015 0.03 0.06 0.125 0.25 0.5 1 2 4 8 16 32 64 128 56 512 1024 2048 >2048 (ug/ml)
Conventional 0 33 36 1 0 4-16
Organic-
Transitioning 1 14 27 0 0 2-8




Transitioning 0 3 15 15 9
a
0.5-≥4
Conventional 3b 6 25 36 ≤0.5-4
Organic-
Transitioning 3b 2 26 11 ≤0.5-4




Transitioning 12b 3 13 10 4
a
≤0.5-≥8




Transitioning 0 3 2 0 37
a
2-≥16




Transitioning 42b 0 0 0 128




Transitioning 20b 19 1 2 ≤128-1024




Transitioning 6b 2 2 3 16 14
a
≤1-≥32
Conventional 0 16 51 2 1 ≤1-8
Organic-
Transitioning 0 7 27 8 0 ≤1-4
G e n t a m i c i n
K a n a m y c i n
L i n c o m y c i n
L i n e z o l i d
No. of Isolates associated with MIC (ug/ml) of:
C h l o r a m p h e n i c o l
C i p r o f l o a x c i n
D a p t o m y c i n
E r y t h r o m y c i n





Table 11: (cont’d) 
 
 Enterococcus faecium (n=113) 
Antimicrobial Production MIC Range
 Agent Practice 0.015 0.03 0.06 0.125 0.25 0.5 1 2 4 8 16 32 64 128 56 512 1024 2048 >2048 (ug/ml)
Conventional 0 0 5 65a 32-≥64
Organic-
Transitioning 0 3 2 37
a
16-≥64




Transitioning 2b 1 9 22 7 1 ≤0.5-≥16
Conventional 64b 3 1 2 ≤512-≥2048
Organic-
Transitioning 41b 0 1 0 ≤512-2048
Conventional 11b 12 32 11 1 3 ≤1-32
Organic-
Transitioning 10b 24 5 2 1 0 ≤1-16




Transitioning 32b 4 0 5
a
≤4-≥32
Conventional 0 19 34 16 1 0.06-0.5
Organic-
Transitioning 1 13 20 8 0 0.03-0.125




Transitioning 0 8 18 15 1 0 2-16
Conventional 48b 17 5 0 ≤0.5-2
Organic-
Transitioning 18b 19 4 1 ≤0.5-4
1  For daptomycin and tigecycline represents number non-susceptible
a Number of isolates with MICs gretater than or equal to the highest concentration on Sensititre plate
b Number of isolates with MICs less than or equal to the lowest tested concentration on Sensititre plate
V a n c o m y c i n
No. of Isolates associated with MIC (ug/ml) of:
S t r e p t o m y c i n
Q u i n u p r i s t i n  
D a l f o p r i s t i n
T e t r a c y c l i n e
T i g e c y c l i n e
T y l o s i n
N i t r o f u r a n t o i n











Table 12: Salmonella spp. isolated from water, poultry litter, and poultry 
feed samples collected from conventional and organic-transitioning poultry 
farms 
   
Poultry House 
Type   
Environmental 
Source 





     
CONVENTIONAL     
(n=24) 
Poultry Litter (1) 29 (24.4) 26(34.2) 3(12.5) 
Poultry Litter (2) 38(31.9) 28(36.8) 3(12.5) 
Poultry Litter (3) 39(32.8) 22(28.9) 6(25) 
Poultry Feed 9(7.56) 0 9(37.5) 
Water (Source) 0 0 0 
Water (Waterline) 0 0 0 






      
 
Table 13:  Distribution of Salmonella species isolated from organic-
transitioning and conventional poultry production systems  
    
Poultry House 
Type    
 
Species      
Identification 
              





     
































































(unidentified) 1(.08) 1(1.32) 0  






Table 14: Distribution of Salmonella species isolated from water, poultry 
litter, and poultry feed samples collected from conventional and organic-
transitioning poultry farms 
House Type     Species      
 S.enteritidis S.gostrup S.infantis S.kentucky S.orion  
Conventional       
       
Poultry Litter 1 (n=12) 0 0 0 12(100) 0  
       
Poultry Litter 2 (n=9) 0 0 0 0 9(100) 
       
Poultry Litter 3 (n=0) 0 0 0 0 0  
       
Poultry Feed (n=0) 0 0 0 0 0  
       
Water: Source (n=3) 0 0 0 0 3(100)  
       
Water: Waterline (n=0) 0 0 0 0 0  
       
Organic-
Transitioning       
       
Poultry Litter 1 (n=76) 14(18.4) 6(7.9) 6(7.9) 49(64) 0  
       
Poultry Litter 2 (n=0) 0 0 0 0 0  
       
Poultry Litter 3 (n=0) 0 0 0 0 0  
       
Poultry Feed (n=0) 0 0 0 0 0  
       
Water: Source (n=0) 0 0 0 0 0  
       










Table 15: Minimal inhibitory concentration (MIC) distributions (µg/ml) for 
15 antimicrobials among Salmonella spp. (n=120) collected from 
conventional and organic-transitioning poultry farms 
 
Salmonella spp. (n=100)
Antimicrobial Production MIC Range
 Agent Practice 0.02 0.03 0.06 0.13 0.25 0.5 1 2 4 8 16 32 64 128 256 512 10 4 (ug/ml)
Conventional 0 17 4 3 2-8
Organic-
Transitioning 31 36 6 3 1-8
Conventional 19b 0 0 0 0 5 1-32
Organic-
Transitioning 69b 0 2 0 2 3a 1-32
Conventional 18b 1 0 0 0 5 1-32
Organic-
Transitioning 57b 16 0 0 0 3a 1-32




Transitioning 47 21 5 3 2-32
Conventional 3 16 0 0 5 0.5-8
Organic-
Transitioning 20 46 6 1 3a 0.5-8
Conventional 19b 0 0 0 0 0 4 1 0.25-32
Organic-
Transitioning 72b 1 0 0 0 0 3 0 0.25-16
Conventional 16 8 4-8
Organic-
Transitioning 34 42 4-8
Ceftriaxone
Chloramphenicol










Table 15: (cont’d) 
Salmonella spp. (n=100)
Antimicrobial Production MIC Range
 Agent Practice 0.02 0.03 0.06 0.13 0.25 0.5 1 2 4 8 16 32 64 128 256 512 10 4 (ug/ml)
Conventional 21b 2 0 0 1 0.015-0.25
Organic-
Transitioning 59b 16 1 0.015-0.125
Conventional 12 9 3 ≤0.5-2
Organic-
Transitioning 22b 44 6 2 2 ≤0.25-4
Conventional 24b 8
Organic-
Transitioning 74b 1 8-64
Conventional 12 11 2-4
Organic-
Transitioning 36 38 2 2-8
Conventional 14b 10 32-64
Organic-
Transitioning 26b 50a 32-64
Conventional 5 19 32-64
Organic-
Transitioning 32 44 32-64
Conventional 14b 10 32-64
Organic-






a Number of isolates with MICs gretater than or equal to the highest concentration on Sensititre plate
b Number of isolates with MICs less than or equal to the lowest tested concentration on Sensititre plate














Table 16: Multi-drug antibiotic resistance profiles of Salmonella spp. 
isolated from conventional and organic-transitioning poultry farm samples  
 
Serovar Kentucky
Antimicrobial resistance profile Organic Conventional
(n=76) (n=24)
AUG-AMP-FOX-TIO-STR-TET 3 (3.94) 5 (21)
STR-TET 47(62) 5(21)








Table 17: Correlation Table of  Environmental Variables associated with 
Conventional and Organic-Transitioning Poultry Houses adjusted by Intra-








































0.58 0.70 -0.29 1.00
Humidity Inside
0.04 -0.42 0.77 -0.37 1.00
Antibiotics (Feed)
1.00 0.45 -0.04 0.58 0.04 1.00
Rain
-0.41 -0.48 0.52 -0.43 0.41 -0.41 1.00
Antibiotics (Water)
0.32 -0.07 -0.21 0.15 0.22 0.32 -0.13 1.00
Antibiotics 
(Hatchery)
1.00 0.45 -0.04 0.58 0.04 1.00 -0.41 0.32 1.00
Vaccine (Hatchery)
0.36 -0.30 0.38 0.20 0.28 0.36 0.14 0.11 0.36 1.00
Antibiotics (Breeder)
0.33 0.60 -0.17 0.44 -0.20 0.33 -0.34 0.10 0.33 -0.11 1.00
Vaccine (Breeder)
0.50 0.68 -0.09 0.67 -0.17 0.50 -0.15 0.16 0.50 -0.17 0.65 1.00
Cloud Cover
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Figure 1: Photograph of Sensititre™ antimicrobial susceptibility testing 





                    
      
 
     
 
 















    
 
 
                 
Poultry House Types: Transitioning to Organic 
(n=10), Conventional Control (n=10)
Conventional Controls Transitional to Organic
 
 











Figure 5: Organic food share market in 2005; Source: OTA’s 2006 






a. Normally produced under contract arrangement with grower 
 













Figure 7: Number of U.S. certified organic poultry animals, 1997-2005; 
Source: USDA, Economic Research Service, 2006b: Organic Agricultural 









































Percentage of Expressed Susceptible, Intermediate, and Resistant Enterococcus





Figure 8: Percentage of Expressed Susceptible, Intermediate, and Resistant 
Enterococcus pp. Isolates from  Conventional Poultry Houses to a 







































Percentage of Expressed Susceptible, Intermediate, and Resistant Enterococcus





Figure 9: Percentage of Expressed Susceptible, Intermediate, and Resistant 
Enterococcus pp. Isolates from Organic-Transitioning Poultry Houses to a 
































Percentage of Total Enterococcus Isolates from Conventional and Organic-










Figure 10: Percentage of Total Enterococcus Isolates from Conventional 
and Organic-transitioning Poultry Houses expressing resistance to a 































Percentage of Enterococcus faecalis Isolates from Conventional and Organic-






Figure 11: Percentage of Enterococcus faecalis I olates from 
Conventional and Organic-transitioning Poultry Houses expressing 































Percentage of Enterococcus faecium Isolates from Conventional and Organic-







Figure 12: Percentage of Enterococcus faecium  Isolates from 
Conventional and Organic-transitioning Poultry Houses expressing 








Percentage of  Expressed Suceptible, Intermediate, and Resistant 




















































































































Figure 13: Percentage of Expressed Susceptible, Intermediate, and 
Resistant Salmonella spp.. Isolates from Conventional Poultry Houses to a 









Percentage of  Expressed Suceptible, Intermediate, and Resistant 




















































































































Figure 14: Percentage of Expressed Susceptible, Intermediate, and 
Resistant Salmonella spp. Isolates from Organic-Transitioning Poultry 


































Percentage of Total Salmonella Isolates from Conventional and Organic-transitioning 






Figure 15: Percentage of Total Salmonella Isolates from Conventional and 








































Percentage of Salmonella kentucky Isolates from Conventional and Organic-






Figure 16: Percentage of Salmonella kentucky Isolates from Conventional 
and Organic-transitioning Poultry Houses expressing resistance to a 








Antibiotic:  Type of antimicrobial agent made from a mold or a bacterium that kills 
(bactericidal), or slows the growth (bacteristatic) of other microbes specifically.  
 
Antimicrobial resistance: Antimicrobial resistance is the result of microbes changing in 
ways that reduce or eliminate the effectiveness of drugs, chemials, or other agents to 
cure or prevent infections. 
CFU: Colony-forming units.  A measure of viable bacterial numbers or count. 
Conventional (CONV): Poultry farm that practices standard methods used widely 
throughout the U.S. industry including the use of antibiotics, other antimicrobials and 
genetically modified organisms (GMOs) in feed 
 
Organic (ORG): Poultry farm that undergoes strict certification process; standards apply 
on Day 1 of a chick’s life 
• No use of antibiotics, other antimicrobials or GMOs in feed 
• No use of pesticides or herbicides on property 
• Increased square footage per bird 
 
Water Activity(A w): A measurement of the equilibrium relative humidity(ERH); 
represents the ratio of the water pressure of sample to the water vapor pressure of pure 
water and reflects the active part of moisture content (unbound water) which can be 







A. Sampling Protocol for UMD/Penn State Poultry Farm    
Study  2008 
 
I. Purpose 
To describe methods for the collection of samples and farm information from poultry 
farms that are maintaining conventional practices and from poultry farms that are 
transitioning to organic practices for the purpose of assessing longitudi al trends of 
bacterial antimicrobial resistance at these farms. 
 
II.   Scope/Limitations 
This protocol applies to all poultry farms that will be included in this study, and 
involves the collection of meteorological data, poultry litter samples, water samples, 
feed samples, and additional data regarding characteristics of poultry houses, 
chickens, breeders and hatcheries. 
 
III.  Requirements 
All personnel carrying out this protocol must obtain personal protective equipment 
and clothing. During sample collection, booties, coveralls, hair covers and gloves will 
be worn by all study personnel. Important: The accompanying “Poultry Farm 
Sampling Questionnaire”  MUST BE FILLED OUT COMPLETELY before leaving 
each of the poultry houses. No abbreviations, please. 
 
IV.   Field Equipment Check List 
Verify that all necessary items are present before beginning this protocol (Table 1). 
 
V. General Terms and Definitions 
a. Conventional:  Refers to standard agricultural practices widespread in the 
industry. Can include use of pesticides, synthetic fertilizers, antibiotics and 
other agribusiness approaches. 
b. Organic:  Of or relating to foodstuff grown or raised without synthetic 
fertilizers or pesticides, antibiotics, chemicals or hormones. 
c. Poultry Litter:  A mixture of manure, feed, feathers, and the sawdust used 




d. Water Activity: Water activity or Aw is the relative availability of water in 
a substance. 
VI.   Data Collection Protocols 
A. General Information 
In this study, 5 poultry farms that are maintaining conventional practices and 5 poultry 
farms that are transitioning to organic practices will be included in this study.  2 poultry 
houses at each of the 10 farms (if possible) will be sampled throughout the s udy, for a 
total of 20 poultry houses.  The “Poultry Farm Sampling Questionnaire” should be filled 
out for each poultry house that will be sampled.  Upon arrival at each poultry house, 
questions 1.1. through 1.8 on the “Poultry Farm Sampling Questionnaire” should be 
completed as follows:  
 
1.1  Sample Date Collection      Record as the month, day, year (e.g. 02/21/2008) 
   
1.2  Poultry Company Name  Record the name of the poultry company 
associated with sampled farm 
   
1.3  Poultry Farm Name  Record the full name of the specific poultry farm 
where the poultry house is located 
   
1.4  Poultry House Code  On each farm, each poultry house that is sampled 
will have a unique poultry house code, i.e. PH1= 
poultry house 1. This same house will be sampled 
on all subsequent sampling trips.  No two poultry 
houses (even if they are on different farms) will 
have the same poultry house code. 
1.5  Poultry House Type  Record  the type of poultry house being sampled: 
a. House  transitioning to organic (intervention) 
group 
b. House maintaining conventional practices 
(control group) 
 
1.6 Length of Time a Farm                 
Has Has Been Organic 
(For Organic Poultry Houses Only)    
Record the time in months that the sampled poultry 
house    has been organic  
   
1.7  Distance from Nearest 
  C Conventional Poultry         H    
House 
 (For Organic Poultry Houses Only)                                  
Record the approximate distance from the sampled 




   
1.8 Other Types of Poultry  
  H Houses on Property 
 (For Organic Poultry Houses Only)                
 Record ANY other types of poultry houses on this 
farm (e.g. antibiotic-free or conventional poultry 
houses on site) 
 
B. Meteorological Conditions 
A portable meteorological instrument will be utilized for the collection of meteorological 
conditions at each poultry house.  This data will be recorded on the “Poultry Farm 
Sampling Questionnaire” in questions 2.1 through 2.5.  As indicated on the “Poultry 
Farm Sampling Questionnaire,” meteorological conditions will be collected both inside 
and outside of the sampled poultry houses. Prior to entering each poultry house, capture 
OUTSIDE meteorological conditions followed by INSIDE conditions as follows: 
 
2.1 Ambient Temperature (OUTSIDE)       Record ambient temperature right  
    outside of the poultry house 
                                                                   
 
2.2 Relative Humidity (OUTSIDE)             Record relative humidity right outside  
    of  the poultry house 
 
2.3 Ambient Temperature (INSIDE)           Record ambient temperature right inside 
                                                                     of the poultry house 
                                                                   
 
2.4 Relative Humidity (INSIDE)                Record relative humidity right inside of  
               the poultry house 
 
 
C. Poultry Litter Sample Collection 
 
In each house, 3 poultry litter samples, from the top 1 to 2 cm of the poultry litter area 
will be collected in ~ 500 g portions from 3 different  locations defined by a 0.5-1.0 m2 
area.  The sampled areas will be chosen at random and each sample will be collected 
using sterile plastic scoops and latex gloves.  Fresh, plastic scoops and disposable gloves 
will be used to sample each new area.  All poultry litter samples will be collected in 
sterile, sealed bags.  
 
Sampling Identification Scheme: 
(NOTE: Each sample will be given a unique sample ID that is a combination of 1) the 
month and year the sample was collected; 2) the poultry house code of the poultry
house where it was collected; 3) the type of  sample; and 4) the sample number from 
that poultry house. For example, a sample with this sample ID# 03_08_PH1_L1 will 
indicate that this sample was collected in March 2008 from poultry house number 
 
 106
one and this sample is the 1st poultry litter sample (L1) from this house. Water 
samples will be indicated with a “W” and feed samples with an “F.”) 
 
Poultry Litter Sample Collection Protocol:  
Step Procedure 
1 
Once inside a poultry house, chose at random 3 locations where the poultry 
litter samples will be collected. Each of the 3 locations should be defined by a 
~0.5-1.0 m2 area.                                                                                                                        
2 
Using latex gloves and a sterile plastic scoop collect ~500 g of poultry litter 
from the top 1 to 2 cm of the defined ~0.5-1.0 m2 poultry litter area.                                                                                         
3 Aseptically, place the sample into a sterile plastic bag and seal. 
4 
Label the bag with the following: the date (e.g. mm/dd/yyyy) and the Sample 
ID (see the description of the sampling identification scheme above), and 
record the Sample ID within the table in Section 3, Sample Information, of 
the “Poultry Farm Sampling Questionnaire.” 
5 
Describe and record the specific location where the poultry litter sample was 
collected                                                                                                                    
(i.e. beneath the waterers, middle of the house, corner of the house, etc.) 
within the table in Section 3, Sample Information, of the “Poultry Farm 
Sampling Questionnaire.” 
6 
Measure the airflow (ft/min) six inches above the location where the sample                                                  
was collected (direct measure from air flow meter) and record the result 
within the table in Section 3, Sample Information, of the “Poultry Farm 
Sampling Questionnaire.” 
7 
Measure and record the water activity (Aw) at the location where the sample                                                                                                
was collected (direct measure from PawKit water activity meter). (We need 
to include specific steps on how they should go about measuring Aw with the 
PawKit) 
8 
Repeat steps 1-8 for each sample.  Be sure to change plastic scoops and 
gloves between each sample. 
 
 
D. Water Sample and Feed Sample Collection 
 
In addition to litter samples, water and feed samples will be coll cted from the poultry 
houses. Water samples will be collected using 500mL, sterilized polyethy ene Nalgene 
wide-mouth environmental sampling bottles (Nalgene, Lima, OH) and feed samples will 
be collected using sterile plastic bags. 1 water sample and 1 feed sample will be 
collected from each poultry house on every other sampling trip. Water s mples will be 
collected from the waterer lines and feed samples will be coll cted from the feed lines 













During every other sample collection trip, collect 1 water sample and 1 feed 
sample from each poultry house. 
2 
WATER SAMPLES: Using latex gloves, collect water sample into a sterile 
Nalgene Bottle from the waterer in the poultry house. (i.e. nipple drinkers, cup 
drinkers etc.) and seal.  
3 
Label the bottle with the following: Date Sampled, Sample ID (e.g. 
3_08_PH1_W1) 
4 
FEED SAMPLES: Using latex gloves and a sterile plastic scoop, collect ~250g 
of feed from the feed lines into a sterile plastic bag.   
5 
Label the bag with the following: Date Sampled, Sample ID (e.g. 
3_08_PH1_F1) 
6 
Repeat steps 1-5 for each sample. B  sure to change plastic scoops and 
gloves between each sample. 
 
 
E. Poultry House Characteristics 
The following information should be filled out in Sections 4 through 7 on the “Poultry 
Farm Sampling Questionnaire.” These data should be collected at he time of sampling 
and should be completed for each poultry house (i.e. There will be one complete 
“Poultry Farm Sampling Questionnaire” filled out for each poultry house).   
 
4.1  Length of Poultry House                      Measure with tape measure and record the 
                                                                     length of the poultry house (ft.).   
 
4.2  Width of the Poultry House                 Measure with tape measure and record the   
        width 
 
4.3  Type of Ventilation                              Record the type of ventilation inside the 
poultry house (i.e. tunnel, drop curtain, 
drop panel). 
 
        
4.4  Type of Poultry Litter                            Record the type of poultry litter inside the 
poultry house (i.e. wood shavings/ 
sawdust, reused poultry litter, etc).                                                                  
 
4.5  Depth of Poultry Litter                          Measure with ruler and record the depth  
of the poultry litter in the poultry house 
 
4.6  Time Since Last Entire Clean-Out        Record the  time since the poultry litter  in 
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    the entire house was change (months). 
                
                                                                           NOTE: This may require input from 
the grower) 
 
4.7  Amount of Total Light                           Measure with light meter and record the 
total light in the poultry house                                                                             
(quantitative measure). 
 
4.8  Degree of Sunlight                                Record the amount of sunlight 
                in the poultry house (qualitative measure). 
 
4.9  Type of Waterer                                     Record the type of waterer inside the  
poultry house (i.e. nipple, cup drinker, 
and trough). 
 
                                                                       
                                                                
 
F. Poultry Farm Characteristics, Chicken Characteristics, Breeder 
Characteristics, and Hatchery Characteristics: Interview with 
Poultry Grower  
 
PLEASE NOTE: ****This portion of the protocol will entail an IN-PERSON   
          interview with each grower on each of the sampled farms. 
The following questions will be asked of the poultry 
grower in order that the remainder of the “Poultry Farm 
Questionnaire” can be 
         completed.    
 
 
INSTRUCTIONS: Go directly to Questions 4.9-7.3 on the “Poultry Farm 
Sampling Questionnaire” for pre-written questions to be administered in person 
to the grower on each sampled poultry farm.   
 
G. Ensure that the “Poultry Farm Sampling Questionnaire” is 
Complete 
 
IMPORTANT: PLEASE DO NOT LEAVE THE POULTRY HOUSE UN TIL 
EVERY FIELD OF THE “POULTRY FARM SAMPLING 
QUESTIONNAIRE” HAS BEEN COMPLETED. FAILURE TO FILL OU T A 
QUESTIONNAIRE COMPLETELY FOR EACH POULTRY HOUSE WILL  




H. Make a copy of the “Poultry Farm Sampling Questionnaire” for 
your records and send the original questionnaire, along with the 
environmental samples, to UMD at the following address: 
 
Amy R. Sapkota 
UMCP School of Public Health 
Maryland Institute for Applied Environmental Health  
2308 HHP Bldg 





B. Poultry Farm Questionnaire 
Poultry Farm Sampling Questionnaire 
UMD/Penn State Poultry Farm Study 2008 
1. General Information 
 
1.1 Sample collection date (mm/dd/yyyy)___________________ 
 
1.2 What is the name of the poultry company? (please 
specify)____________________________ 
 
1.3 What is the name of the specific poultry farm? (please 
specify)_________________________ 
 
1.4 What is the poultry house code? _______ (On each farm, we will assign each poultry 
house that we sample a unique poultry house code, such as PH1 for poultry house 1. 
This same house will be sampled on all subsequent sampling trips.) 
 
1.5 In what year was the poultry house built? _____ 
 
1.6 What is the type of poultry house? (Circle one) 
 
a) House transitioning to rganic (intervention group) [If it is this type of 
poultry house, go to question 1.7] 
 
b) House maintaining conventional practices (control group) [If it is this type 
of poultry house, SKIP to question 2] 
 
1.7 How long has this poultry house been an organic house? _____months 
 
1.8 What is the approximate distance from this organic poultry house to the nearest 
conventional poultry house? (Circle one) 
a) < ½ mile 
b) ½ mile to 1 mile 
c) 2 to 5 miles 
d) 6 to 10 miles 
e) >10 miles 
 
1.9 Are there other types of poultry houses on this farm? (Circle one) 
f) Yes, there are also antibiotic-free poultry houses on this farm 
g) Yes, there are also conventional poultry houses on this farm 
h) No 
 
2. Meteorological Conditions (To be measured with portable meteorological instrument) 
 2.1 What is the ambient temperature right ou side of the poultry house? ____°F 
 




 2.3 What is the ambient temperature inside of the poultry house? ______°F 
 
  2.4 What is the relative humidity inside of the poultry house? ______% 
 
 2.5 Was it raining when the samples were collected? (Circle one)     Yes  No 
 
 2.6 What were the cloud/sun conditions at the time samples were collected? (Circle one) 
  a) Clear and sunny (Free from clouds, fog, mist or dust haze) 
  b) Mostly sunny (Little chance of the sun being obscured by clouds) 
  c) Partly cloudy (Predominantly more clouds than clear sky) 





3. Sample Information 
(NOTE: Each sample will be given a unique sample ID that is a combination of 1) the month, day and year the sample was collected; 2) the poultry house 
code of the poultry house where it was collected; 3) the type of  sample; and 4) the sample number from that poultry house. For example, a sample with this 
sample ID# 03_31_08_PH1_L1 will indicate that this sample was collected on March 31, 2008 from poultry house number one and this sample is the 1st 
poultry litter sample (L1) from this house. Water samples will be indicated with a “W” and feed samples with an “F.”) 
 
Fans ON Fans OFF
Litter Under feeder
Litter Under waterer
Litter Middle of house
Water Source (or source after primary treatment) Not applicable Not applicable Not applicable Not applicable
Water End of line Not applicable Not applicable Not applicable Not applicable
Feed Hopper in house Not applicable Not applicable Not applicable Not applicable
Soil* Outside Not applicable Not applicable Not applicable Not applicable
Booties Not applicable Not applicable Not applicable Not applicable Not applicable
Sample ID#
*NOTE: At organic farms, a soil samples will be collected from the area where the chickens are allowed out oors. At the conventional farms, a soil sample wi l be collected from an 
area where poultry is land-applied if possible.
What was the water 
activity (Aw) at the 
location where the 
sample was collected? 
(Direct reading from 
water activity meter)
What was the amount of light 
(lux) 12 inches  above the location 
where the sample was collected? 
(Direct reading from light meter)
What was the airflow 
(ft/min) six inches  above 
the location where the 
sample was collected? 
(Direct reading from airflow 
meter)
Where was the sample collected within 
the poultry house? (ie. beneath the 
drinkers; in the middle of the house; from 















4. Poultry House Characteristics 
 4.1 **What is the length of the poultry house? _____feet 
 
 4.2 **What is the width of the poultry house? _____feet 
 
 4.3 What type of ventilation system is in use inside the poultry house? (Circle one) 
  a) Tunnel ventilation 
  b) Drop curtain 
  c) Mechanically ventilated 
  d) Other (please specify)____________________ 
 
 4.4 What was the type of poultry litter  in the poultry house at the time of sampling? 
(Circle one) 
  a) Wood shavings/sawdust 
  b) Reused poultry litter/Build-up 
  c) Peanut hulls 
  d) Rice hulls 
  e) Other (please specify)____________________ 
   
 4.5 What is the depth of the poultry litter at the poultry litter sampling location that was 
away from both the         drinkers and the feed lines? ____ inches 
 
 4.6 **How long ago was the poultry litter in the entire house changed? _____months 
  
 4.7 How much sunlight was in the poultry house at the time of sampling? (Circle one) 
  a) A lot of sunlight 
  b) Some sunlight 
  c) Not a lot of sunlight 
  d) Very little sunlight 
  e) No sunlight 
 
 4.8 What is the type of drinker  in the poultry house? (Circle one) 
  a) Nipple drinkers 
  b) Cup drinkers 
  c) Bell drinkers 
  c) Other 
 
 4.9 What is the design of the drinker system in the poultry house? (Please 
specify)______________________ 
 
 4.10 What is the design of the feed system in the poultry house? (Please 
specify)________________________ 
   
 NOTE: You will need to conduct an interview with each poultry grower to answer 
the following questions.   
 It is possible, that the grower (particularly the conventional growers) will not have 
answers for the   
      following questions:  4.13, 4.14, 6.1, 6.2, 6.3, 6.4, 6.5, 6.6, and 6.7. If this is the case, 
we will have to ask these  




 4.11 **What is the source of water for the poultry house? 
  a) Well water 
  b) Public water supply 
  c) Other (please specify)____________________ 
 
 4.12 **What company supplies the poultry feed? (please specify) 
____________________ 
 
 4.13 **What type of feed was used in the poultry house at the time of sampling? 
  a) Broiler Starter 
  b) Broiler Grower/Finisher 
  c) Broiler Grower Concentrate 
  d) Other (please specify)____________________ 
 
 4.14 **Were antibiotics/antimicrobials used in the poultry feed for the current flock? 
(Circle one)  
         Yes     No 
 
 4.15 **If antibiotics/antimicrobials were used in the poultry feed, what specific 
antibiotics/antimicrobials            
              were used for this flock at any time before or during sampling? (Circle all that 
apply) NOTE: Most likely,           the growers will not know this 
information, so we will need to obtain it from the company.  
  a) No antibiotics/antimicrobials were ever used in the poultry feed of this flock 
  b) Bambermycin 
  c) Bacitracin 
  d) Chlortetracycline 
  e) Oleandomycin 
  f) Penicillin 
  g) Tylosin 
  h) Tetracycline 
  i) Virginiamycin 
  j) Lincomycin 
  k) Arsanilic acid 
  l) Roxarsone 
  m) Carbarsone 
  n) Salinomycin 
  o) Lasalocid  
  p) Narasin 
  q) Monensin 
  r) Other (please specify)_____________________ 
  s) Other (please specify)_____________________ 
  t) Other (please specify)_____________________ 
 
 4.16 **Were antibiotics/antimicrobials used in the water for the current flock? (Circle 
One) Yes     No 
 
 4.17 **If antibiotics/antimicrobials were used in the poultry water, what specific 
antibiotics were used for          this flock at any time before or during sampling? 
NOTE: The grower will have this information. 
  a) No antibiotics/antimicrobials were used in the water for this flock 
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  b) Bacitracin 
  c) Chlortetracycline 
  d) Tylosin 
  e) Fluoroquinolone 
  f) Other (please specify)_____________________ 
  g) Other (please specify)_____________________ 
  h) Other (please specify)_____________________ 
 
 4.18 **Were any other feed or water additives used for the current flock? (Circle one) 
  Yes       No 
 
4.19 If any other feed or water additives were used for the current flock, what specific 
additives were used? (Circle all that apply) 
a) No other feed or water additives were used for the current flock 
b) Citric acid (in water) 
c) Vitamin D (in water) 
d) PWT (pH amendment) 
e) Acidified Cu (copper) sulfate 
f) Other (please specify)_____________________ 
 
 
5. Chicken Characteristics 
 5.1 **What was the number of chickens introduced with the current flock? __________ 
chickens 
 
 5.2 **What was the strain of the current flock? 
  a) Ross 
  b) Ross Cobb 
  c) Cobb/Cobb 
  d) Mixture (Please specify)___________________________   
______________________________ 
  e) Other (please specify)_____________________ 
 
 5.3 **What was the age (in days) of the flock at the time of sampling? ______ days 
 
 5.4 **What was the date that the current flock arrived at the farm (ie. the “date in”)   
 
       (mm/dd/yyyy)___________________ 
 
 5.5 **What was the mortality rate (%) of the current flock at the time of sampling? 
______% 
 
 5.6 **What is the average amount of time (minutes) the current flock spends outdoors 
each day?_____ min 
 
6. Hatchery Characteristics (NOTE: We may have to ask the company for the following 
information) 
 
 6.1 **What is the name of the hatchery where the current flock came from?(please 
specify)  




 6.2 **Does this hatchery use antibiotics/antimicrobials for any purpose? (Circle one) 
Yes     No 
 
 6.3 **If the hatchery does use antibiotics/antimicrobials for any purpose, what specific 
compounds are                  
            used? 
             a) No antibiotics/antimicrobials were used at the hatchery 
  b) Gentamicin 
  c) Naxcel (Cephalosporin) 
  d) Other (please specify)_____________________ 
  e) Other (please specify)_____________________ 
  f) Other (please specify)_____________________ 
 
 6.4 **Does the hatchery use vaccinations for any purpose? (Circle one) Yes     No 
 
 6.5 **If the hatchery does use vaccinations, what specific vaccinations are used? (Circle 
all that apply) 
  a) No vaccinations are used 
  b) Coccivac 
  c) Merrick’s 
  d) Newcastle 
  e) Bronchitis 
  f) HVT/SB1 
  g) IBD 
  h) N/B New Hatch 
  i) Other (please specify)_____________________ 
   
 6.6 **Does the hatchery use probiotics for any purpose? (Circle one) Yes     No 
 
 6.7 **If the hatchery does use probiotics, what are the specific compounds that are used? 
(Circle all that apply) 
  a) No probiotics are used 
  b) Avacor 
  c) Other (please specify)_____________________ 
 
7. Breeder Characteristics (NOTE: We may have to ask the company for the following 
information) 
 
 7.1 **What is the name of the breeder(s) where the current flock came fro ?(please 
specify)  
       
      _______________________ 
 
 7.2 **Does this breeder(s) use antibiotics/antimicrobials for any purpose? (Circle one) 
Yes     No 
 
 7.3 **If the breeder(s) does use antibiotics/antimicrobials for any purpose, what 
specific compounds are                 
            used? 
             a) No antibiotics/antimicrobials were ever used in the poultry feed of this flock 
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  b) Bambermycin 
  c) Bacitracin 
  d) Chlortetracycline 
  e) Oleandomycin 
  f) Penicillin 
  g) Tylosin 
  h) Tetracycline 
  i) Virginiamycin 
  j) Lincomycin 
  k) Arsanilic acid 
  l) Roxarsone 
  m) Carbarsone 
  n) Salinomycin 
  o) Lasalocid  
  p) Narasin 
  q) Monensin 
  r) Other (please specify)_____________________ 
  s) Other (please specify)_____________________ 
  t) Other (please specify)_____________________ 
 
 7.4 **Does the breeder(s) use vaccinations for any purpose? (Circle one) Yes     No 
 
 7.5 **If the breeder(s) does use vaccinations, what specific vaccinations are used? 
(Circle all that apply) 
  a) No vaccinations are used 
  b) Coccivac 
  c) Merrick’s 
  d) Newcastle 
  e) Bronchitis 
  f) HVT/SB1 
  g) IBD 
  h) N/B New Hatch 
  i) Wormer 
  j) Rheovirus 
  k) Other (please specify)_____________________ 
 
 7.6 **Does the breeder(s) use probiotics for any purpose? (Circle one) Yes     No 
 
 7.7 **If the breeder(s) does use probiotics, what are the specific compounds that are 
used? (Circle all that apply) 
  a) No probiotics are used 
  b) Avacor 




C. Enterococcus Protocol (Isolation from Poultry Litter and 
Poultry Feed) 
 
Objective: Enrichment experiment for isolating, purifying, and archiving Enterococcus  
derived from poultry litter and feed samples using Enterococcosel Broth (Difco), 
Enterococcosel Agar and BHI Agar.   
 
Pre Sample Arrival(Week Before) 
1. Calculate the amount of Broth and Agar needed for sample processing. 
2. Prepare Enterococcosel Broth 
a. Suspend 43 g of the powder in a 1 L of d H20 
b. Mix thoroughly , heat and boil for 1 min to completely dissolve the 
powder. 
c. Autoclave at 121C for 30 min 
d. Cool to 50 °C 
e. Place in the refrigerator at 4°C for later use. 
 
3. Prepare Enterococcosel Agar 
a. Suspend 56 g of powder in 1 L of dH20. 
b. Mix thoroughly , heat and boil for 1 min to completely dissolve the 
powder. 
c. Autoclave at 121C for 30 min 
d. Cool to 50 °C 
e. Pour into 100 x 15mm Petri dishes and store. 
f. Place in the refrigerator at 4°C for later use. 
 
4. Prepare BHI Agar 
a. Suspend 52 g of powder in 1 L of dH20. 
b. Mix thoroughly, heat and boil for 1 min to completely dissolve the 
powder. 
c. Autoclave at 121C for 30 min 
d. Cool to 50 °C 
e. Pour into 100 x 15mm Petri dishes and store. 
f. Place in the refrigerator at 4°C for later use. 
 
Day 1:  Sample Arrival and Enrichment 
1. Label all sample containers (133 mL) with the appropriate poultry house, sample 
media code, i.e. PH1_LI, etc. 
2. Aseptically weigh and add 10 grams of poultry litter/feed into 133 mL sample 
containers. Under the BSC, aseptically add 100mL of Enterococcosel Broth to 
each 133mL sample container.   
3. Swirl gently to evenly distribute the Enterococcosel Broth among the sample.   
4. Place the container into the incubator overnight (24 hr) at 41°C. 




Day 2:   Isolation 
Today you will streak your enrichment culture for isolation on Enterococcosel agar 
(EA) media.  EA has nutrients appropriate for the growth of enterococci and will 
presumptively select for enterococci. Additionally, this media contains bile esculin 
and sodium azide, and therefore, in the presence of enterococci species, a brown-
black precipitate will be visible beneath the presumptive colony in the agar. 
  
Obtain your poultry litter/feed enrichment culture from the incubator nd obtain an 
EA plate. 
1. Label your EA plate (Initials, Date, PH1_L1,ENT). 
2. Take a 10ul loopful of your enrichment culture and streak your plate for isolation 
of Enterococcus. Incubate overnight at 41 °C. 
3. Streak a (+) control and (-) control plate and incubate overnight at 41 °C. 
 
Day 3:  Purification  
Target colony:  Very small, LightDark brown colonies with black precipitate; Take 
3 target organisms from each sample and streak for purification onto BHI. 
 
Today you will streak your enterococci culture for purification on BHI agar media.   
Obtain your EA plate from the incubator and record results (i.e. presenc  of absence 
of typical enterococci growth) 
1. Label your BHI plate (Initials, Date, PH1_L1,ENT). 
2. Select 3 target colonies and streak each colony onto your BHI platefor 
purification of each Enterococcus isolate. Incubate overnight at 41 °C. 
3. Streak a (+) control and (-) control plate and incubate overnight at 41°C. 
 
Day 4:   Biochemical Testing 
 
Today you will do a Gram Stain, catalase test and PYR test to presumptively identify 
Enterococcus from your positive poultry litter/feed samples. 
  
• The Gram stain will confirm that you have a pure culture and it will also confirm 
that you have a Gram positive coccus (morphology and gram reaction for 
Enterococcus).   
• The PYR test is a rapid, colorimetric test recommended for use in qualitative 
procedures for the detection of pyrrolidonyl arylamidase activity for presumptive 
identification of enterococcoci, group A streptococcoci, and Escherichia coli. 
• The catalase test examines the ability to breakdown hydrogen peroxide by 
catalase. Those organisms possessing the catalase enzyme will break down 
hydrogen peroxide into water and oxygen.  The oxygen causes bubbles to form 
within, seconds, indicating a positive test.  The absence of bubbles is considered 
a negative test.  Enterococcus is catalase negative (or very weakly positive).  
 
Obtain your BHI purification plates from the incubator and record results. Make sure 




1. Gram Stain 
a. Perform Gram Stain as directed 
b. Record observations 
 
2. PYR Test 
a. Test isolates should be 18-24 hours old and taken from non-selective 
media, such as BHI 
b. Using forceps, place the disk on a clean microscope slide or in thelid of a 
Petri dish free from excess moisture.   
c. Moisten the disk slightly with 5-10 ul of demineralized water using a 
micropipette or a 10 uL inoculating loop.  DO NOT OVERSATURATE. 
d. Remove a visible “paste” of the test isolate using a sterile loop. 
e. Rub the inoculums gently into a small area of the disk. 
f. Add one (1) drop of PYR Reagent to the disk. 
g. Allow up to one minute for a color change. 
i. Positive test= pink to red color development w/in 1 min of 
applying PYR reagent 
ii.  Negative test= Cream, yellow, or no color change within one 
minute of applying PYR Reagent 
 
3. Catalase Test 
a. Collect an empty Petri dish and place one drop of 3 % hydrogen 
peroxide/per sample on to surface of Petri dish 
b. Take small swab from each sample and place into the 3 % hydrogen 
peroxide. 
c. Examine plates for bubbles.  Presence of bubbles= positive result; 
Absence of bubbles =negative result 
d. Record observations 
 
IMPORTANT:  If you have Black precipitate, (+) gram stain, (+) PYR test, and (-) 
(or very weakly positive) catalase test, then archive the isolate as follows: 
 
Day 4 or 5:  Archiving of Sample Isolates 
 
Today you will archive Enterococcus isolates from your BHI purification plates. 
  
Obtain your BHI purification plates from the incubator.  Also obtain Brucella Broth 
w/ 15% glycerol 
 
1. Observe and record the results of your BHI plate.  Compare your plate to the 
control plate and make sure that you have a pure (and NOT mixed) culture.   
2. Label your Brucella Broth w/ 15% glycerol tube with the following formation: 
(Date of sampling, PH_L1_E1… E2…E3…( Each isolate will have a continuous 
number independent of the poultry house label). 
3. Using a sterile swab, collect a substantial amount of enterococci.  Place into the 
Brucella Broth and gently swirl in order to get remainder off of cotton swab. 
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4. On laboratory data sheet, record information about isolate including location in 





D.  Salmonella Protocol (Isolation from Poultry 
Litter and Poultry Feed) 
 
Objective: Enrichment experiment for the isolation, purification, and rchiving of 
Salmonella derived from poultry litter and feed samples using Lactose Broth, TT Hajna 
Broth (Difco), XLT4 agar and BHI agar.   
 
PreSample Arrival(Week Before) 
5. Calculate the amount of Broth and Agar needed for sample processing. 
6. Prepare Lactose Broth 
a. Suspend 13 g of the powder in 1 L of d H20 
b. Mix thoroughly, heat and boil for 1 minute to completely dissolve the 
powder. 
c. Autoclave at 121C for 30 min 
d. Cool to 50 C 
e. Place in the refrigerator at 4C for later use. 
7. Prepare TT Hajna  Broth 
a. Suspend  91 g of the powder in a 1 L of d H20 
b. Mix thoroughly, heat and boil for 1 minute to completely dissolve the 
powder. 
c. Cool to 50 C in waterbath 
d. Place in the refrigerator at 4C for later use. 
 
8. Iodine Solution 
a. 40 mL iodine Solution 
i. 5 g of iodine crystals and 8 g of potassium iodide dissolved in 40 
mL dH20 
ii.  Store in bottle wrapped in aluminum foil at 4C 
 
9. Prepare XLT4 Agar 
a. Suspend 59 g of powder in 1 L of dH20. 
b. Add 4.6 mL of XLT4 Agar Supplement (is the supplement added after the 
boiling step?) 
c. Mix thoroughly, heat and boil for 1 minute to completely dissolve the 
powder. (total time 20-25 minutes) 
d. DO NOT AUTOCLAVE 
e. Cool to 50 C 
f. Pour into 100 x 15mm Petri dishes and store. 
g. Place in the refrigerator at 4°C for later use. 
 
10. Prepare BHI Agar 
a. Suspend 52 g of powder in 1 L of dH20. 




c. Autoclave at 121C for 30 min 
d. Cool to 50 °C 
e. Pour into 100 x 15mm Petri dishes and store. 
f. Place in the refrigerator at 4°C for later use. 
 
11. Triple Sugar Iron Agar (TSI) 
a. Suspend 59.4 g of powder in 1 L of dH20. 
b. Mix thoroughly, heat and boil for 1 min to completely dissolve the 
powder. 
c. Sterilize by autoclaving at not over 118C for 15 min  
d. Cool in a slanted position such that deep butts are formed 
e. Place in the refrigerator at 4°C for later use. 
 
12. Lysine Iron Agar (LIA)  
a. Suspend 34.5 g of powder in 1 L of dH20. 
b. Mix thoroughly, heat and boil for 1 min to completely dissolve the 
powder. 
c. Autoclave at 121C for 12 min 
d. Cool in a slanted position such that deep butts are formed (at least 4cm) 
e. Place in the refrigerator at 4°C for later use. 
 
 
Day 1:  Sample Arrival and Pre-Enrichment 
 
6. Label all sample containers (133 mL) with the appropriate poultry house, sample 
media ID, i.e. PH1_LI, etc. 
7. Aseptically weigh and add 10 grams of poultry litter/feed into 133 mL sample 
containers. Under the BSC, aseptically add 100mL of Lactose Broth to each 133 
sample container.   
8. Swirl gently to evenly distribute the Lactose Broth among the sample.   
9. Place the container into the incubator overnight (24 hr) at 37°C. 
10. Set up a positive (+) and negative (-) control broth 
 
Day 2:  Enrichment 
 
Today you will perform the enrichment step for Salmonella 
1. Obtain your poultry litter/feed Salmonella inoculums from the incubator and 
obtain sterile 133mL sample container cups. 
2. Label your sample container (Initials, Date, PH1_L1 SAL) 
3. Add iodine solution (1.2 mL per 15mL of Hajna) 
4. From the Lactose Broth suspension, add an aliquot (1mL) of the suspension to 15 
mL Hajna Tetrathionate broth (make sure to add iodine solution). 
5. Incubate overnight at 37C 
6. 2nd Enrichment: Leave TT Hajna enrichments on bench for 4 nights (if samples 
are initially negative, these secondary enrichments will be used to double check 




Day 3:    Isolation 
Today you will streak your Salmonella culture for isolation on XLT4 agar media.  
XLT4 has nutrients appropriate for the growth of Salmonella and will presumptively 
select for Salmonella.   If Salmonella is present, the media will turn a yellow color 
and the colonies will appear either completely black or yellow-ish with a black center.  
 
Obtain your poultry litter/feed enrichment culture from the incubator nd obtain an 
XLT4 plate. 
4. Label your XLT4 plate.(Initials, Date, PH1_L1,SAL) 
5. Take a 10ul loopful of your enrichment culture and streak your plate for isolation 
of Salmonella. Incubate overnight at 37 °C.  
6. Streak a positive and negative control plate and incubate overnight at 37C. 
 
Day 4:  Purification 
Target colony:  Black colonies associated with a color change (to yellow) on XLT4 
agar.  If positive, Take 3 target organisms from each sample and streak onto BHI. If 
other samples are negative, take 10 colonies from the positive samples.  On amples 
without target organisms, return to step 6 under Day 2: 2nd Enrichment and restreak 
from TT Hajna 5 days after the initial enrichment.  Place plates back into the 37C 
incubator and check after 24-48 hours.   
 
Today you will streak your isolated colonies for purification on BHI agar.   
Obtain your XLT4 plates from the incubator and record results of the isolation step 
(i.e. Presence or absence of typical S monella growth). 
4. Label your BHI plate (Initials, Date, PH1_L1,ENT). 
5. Select 3 to 10 isolated target colonies and streak each colony for purification on a 
BHI plate. Incubate overnight at 37 °C. 
6. Streak a positive control plate and a negative control plate and incubate overnight 
at 37C. 
 
Day 4:   Biochemical Testing 
 
Today you will do LIA and TSI agar slant tests to presumptively identify the 
Salmonella isolates from each of your poultry litter/feed sample.  
 
• The TSI agar slant test examines the ability of a microorganism to ferment 
sugars and to utilize iron to produce hydrogen sulfide. Presumptive (+) 
cultures have alkaline (red) slants and acid (yellow) butts, with or without 
H2S production (blackened agar). Do not exclude H2S negative slants. 
 
• The LIA agar slant test examines the microorganisms’ ability for lysine 
decarboxylantion, lysine deamination(formation of red-colored products at the top of 
medium) and hydrogen sulfide production (black precipitate).LIA: Presumptive (+) 
cultures have an alkaline (purple) slants and alkaline(purple) butts. Consider only a 
distinct yellow coloration in the butt as an acid (negative) reaction.  *** Do not 
 
 125
eliminate cultures that produce discoloration in butt of tube solely n this basis. Most 
Salmonella cultures produce H2S in LIA. Some non- Salmonella cultures produce a 
brick-red reaction in LIA slants. 
 
• Regardless of TSI reaction, all cultures that give an alkaline butt in LIA 
should be retained as presumptive  Salmonella isolate.  Cultures that give an 
acid butt in LIA and an alkaline slant & acid butt in TSI should be retain d as 
potential Salmonella isolates.  Cultures with an acid butt in LIA, acid slant & 
acid butt in TSI should be discarded as non-Salmonella. 
 
 
Obtain your BHI plates from the incubator and record results. 
 
4. TSI and LIA agar slant test 
a. With sterile inoculating loop, lightly touch the center of a chosen colony. 
b. Inoculate TSI slant by streaking slant and stabbing butt. 
c. Without flaming, inoculate LIA slant by stabbing but twice (2) and then 
streaking slant. LIA slants must have a deep butt (4cm). 
d. Incubate TSI and LIA slants at 35°C for 24 ± 2 h.  
e. Loosely cap tubes  to maintain aerobic conditions while incubating slats 
for the prevention of  excessive H2S production 
 
 
IMPORTANT:  If you have Black colonies with yellow agar color change on XLT4 
agar, (+) LIA agar slant, (+) TSI agar slant (or the exceptions noted above) then 
archive the isolates as follows: 
 
Day 5 or 6:   Archiving of Sample Isolates 
 
Today you will archive your purified isolates that are currently on BHI plates.   
 
Obtain your BHI plates from the incubator.  Also obtain Brucella Broth w/ 15% 
glycerol 
 
5. Observe and record the results of your BHI plate.  Compare your plate to the 
control plate and make sure that you have a pure (and NOT mixed) culture. 
6. Label your Brucella Broth w/ 15% glycerol tube with the following formation: 
(Date of sampling, PH_L1_SAL1… SAL2…SAL3… (Each isolate will have  
continuous number independent of the poultry house label). 
7. Using a sterile swab, collect one Salmonella colony from each purification.  Place 
into the Brucella Broth w/ 15% glycerol and gently swirl in order to get remainder 
off of cotton swab. 
8. On laboratory data sheet, record information about isolate including location in 
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o The two-step approach will allow rapid and accurate discrimination of the Campy 
species that are implicated in human infections. 
o  Multiple species can be discriminated with a single PCR assay.      
o The assay will be designed as a rapid classification tool for clinical laboratories, 
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Invertebrate Assemblages in Headwater Streams, (Coweeta National Hydro ogical 
Laboratory, NC) 
        
           Atlanta Outward Bound Center AmeriCorps       Dates Employed: 09/2002-06/2003 
           3790 Market Street                        Clarkston, GA 30021 
 
EcoWatch AmeriCorps Member 
 
• A ten-month commitment through United States Americorps Program and the 
Atlanta Upward Bound Center to complete 1700 hours of environmentally oriented 
community service in Georgia 
• Performed biological and chemical water testing under Georgia’s Adopt-A-Stream 
Program 
• Constructed and maintenance of nature trails, organic community gardens, and 
conservation  projects 
• Instructed environmental education classes and programs for K-12 students in 
Georgia 
• Developed and operated an environmentally focused After-School Program at 
Clairemont Elementary School 
 
           United States Environmental Protection Agency    Dates Employed: 08/2001-7/2002 
           1200 Pennsylvania Ave, NW                                                    Washington  D.C., 20460              
 
Clean Air Program Analyst 
• Conducted studies and analyses in the formulation of the Clean Air Budget in the 
Office of                             Program Management Operations for the Office of Air 
and Radiation 
• Reviewed project and program effectiveness in achieving Goal 6: Reduction of 
Global and                              Cross Border Environmental Risks through preparation 
of the U.S. EPA 2001 Annual                                  Report for OAR 
 
        




AWARDS, HONORS AND PROFESSIONAL MEMBERSHIPS 
   
• Dean’s Scholar : UMD School of Public Health (2009) 
• Golden Key National Honor Society (2008- Present) 
• University of Maryland College Park Dean’s List (2007-Present) 
• Clark Atlanta University Dean’s List (4 years) 
• American Public Health Association Student Member (2007- Present) 
• American Society of Microbiology Student Member (2007-Present) 
• Association for the Advancement of Science (AAS) Student Member (2005-Present) 
• Ecological Society of America Professional Member (2001-2002) Student Member (2005-
Present) 
• Sierra Club Member (2003-Present) 
• CSX Corporation/ National Audubon Society Scholar (1999-2002) 
• ACWA Outstanding Scholar Program EPA (2001-2002) 
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